<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Corticosteroids for acute bacterial meningitis - Brouwer, MC - 2015 | Cochrane Library</title> <meta content="Corticosteroids for acute bacterial meningitis - Brouwer, MC - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Corticosteroids for acute bacterial meningitis - Brouwer, MC - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004405.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Corticosteroids for acute bacterial meningitis" name="citation_title"/> <meta content="Matthijs C Brouwer" name="citation_author"/> <meta content="Academic Medical Center University of Amsterdam" name="citation_author_institution"/> <meta content="Peter McIntyre" name="citation_author"/> <meta content="Children's Hospital at Westmead and University of Sydney" name="citation_author_institution"/> <meta content="Kameshwar Prasad" name="citation_author"/> <meta content="All India Institute of Medical Sciences (AIIMS)" name="citation_author_institution"/> <meta content="Diederik van de Beek" name="citation_author"/> <meta content="University of Amsterdam" name="citation_author_institution"/> <meta content="D.vandeBeek@amc.uva.nl" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD004405.pub5" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/09/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004405.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti-Inflammatory Agents [adverse effects, therapeutic use]; Developed Countries; Developing Countries; Dexamethasone [therapeutic use]; Glucocorticoids [adverse effects, *therapeutic use]; Hearing Loss [etiology, prevention &amp; control]; Hydrocortisone [therapeutic use]; Meningitis, Bacterial [complications, *drug therapy, mortality]; Prednisolone [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004405.pub5&amp;doi=10.1002/14651858.CD004405.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="JmNqPX1V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004405\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004405\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","pl","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004405.pub5",title:"Corticosteroids for acute bacterial meningitis",firstPublishedDate:"Sep 12, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004405.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004405.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004405.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004405.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004405.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004405.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004405.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004405.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004405.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004405.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>24051 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004405.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0068"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-sec-0059"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/appendices#CD004405-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/table_n/CD004405StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/table_n/CD004405StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Corticosteroids for acute bacterial meningitis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#CD004405-cr-0002">Matthijs C Brouwer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#CD004405-cr-0003">Peter McIntyre</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#CD004405-cr-0004">Kameshwar Prasad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information#CD004405-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Diederik van de Beek</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information/en#CD004405-sec-0101">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 September 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004405.pub5">https://doi.org/10.1002/14651858.CD004405.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004405-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004405-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004405-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004405-abs-0009">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004405-abs-0001" lang="en"> <section id="CD004405-sec-0001"> <h3 class="title" id="CD004405-sec-0001">Background</h3> <p>In experimental studies, the outcome of bacterial meningitis has been related to the severity of inflammation in the subarachnoid space. Corticosteroids reduce this inflammatory response. </p> </section> <section id="CD004405-sec-0002"> <h3 class="title" id="CD004405-sec-0002">Objectives</h3> <p>To examine the effect of adjuvant corticosteroid therapy versus placebo on mortality, hearing loss and neurological sequelae in people of all ages with acute bacterial meningitis. </p> </section> <section id="CD004405-sec-0003"> <h3 class="title" id="CD004405-sec-0003">Search methods</h3> <p>We searched CENTRAL (2015, Issue 1), MEDLINE (1966 to January week 4, 2015), Emabse (1974 to February 2015), Web of Science (2010 to February 2015), CINAHL (2010 to February 2015) and LILACS (2010 to February 2015). </p> </section> <section id="CD004405-sec-0004"> <h3 class="title" id="CD004405-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of corticosteroids for acute bacterial meningitis.</p> </section> <section id="CD004405-sec-0005"> <h3 class="title" id="CD004405-sec-0005">Data collection and analysis</h3> <p>We scored RCTs for methodological quality. We collected outcomes and adverse effects. We performed subgroup analyses for children and adults, causative organisms, low‐income versus high‐income countries, time of steroid administration and study quality. </p> </section> <section id="CD004405-sec-0006"> <h3 class="title" id="CD004405-sec-0006">Main results</h3> <p>We included 25 studies involving 4121 participants (2511 children and 1517 adults; 93 mixed population). Four studies were of high quality with no risk of bias, 14 of medium quality and seven of low quality, indicating a moderate risk of bias for the total analysis. Nine studies were performed in low‐income countries and 16 in high‐income countries. </p> <p>There was insufficient evidence that corticosteroids caused a reduction in mortality overall (17.8% versus 19.9%; risk ratio (RR) 0.90, 95% confidence interval (CI) 0.80 to 1.01; P = 0.07), or for adults (RR 0.74, 95% CI 0.53 to 1.05; P = 0.09). However they caused lower rates of severe hearing loss (RR 0.67, 95% CI 0.51 to 0.88), any hearing loss (RR 0.74, 95% CI 0.63 to 0.87) and neurological sequelae (RR 0.83, 95% CI 0.69 to 1.00). </p> <p>Subgroup analyses for causative organisms showed that corticosteroids reduced mortality in <i>Streptococcus pneumoniae</i> (<i>S pneumoniae</i> ) meningitis (RR 0.84, 95% CI 0.72 to 0.98), but not in <i>Haemophilus influenzae</i> (<i>H influenzae</i> ) or<i>Neisseria meningitidis</i> (<i>N meningitidis</i> ) meningitis. Corticosteroids reduced severe hearing loss in children with <i>H influenzae</i> meningitis (RR 0.34, 95% CI 0.20 to 0.59) but not in children with meningitis due to non‐<i>Haemophilus</i> species. </p> <p>In high‐income countries, corticosteroids reduced severe hearing loss (RR 0.51, 95% CI 0.35 to 0.73), any hearing loss (RR 0.58, 95% CI 0.45 to 0.73) and short‐term neurological sequelae (RR 0.64, 95% CI 0.48 to 0.85). There was no beneficial effect of corticosteroid therapy in low‐income countries. </p> <p>Subgroup analysis for study quality showed no effect of corticosteroids on severe hearing loss in high‐quality studies. </p> <p>Corticosteroid treatment was associated with an increase in recurrent fever (RR 1.27, 95% CI 1.09 to 1.47), but not with other adverse events. </p> </section> <section id="CD004405-sec-0007"> <h3 class="title" id="CD004405-sec-0007">Authors' conclusions</h3> <p>Corticosteroids significantly reduced hearing loss and neurological sequelae, but did not reduce overall mortality. Data support the use of corticosteroids in patients with bacterial meningitis in high‐income countries. We found no beneficial effect in low‐income countries. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004405-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004405-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004405-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004405-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004405-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004405-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004405-abs-0005">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004405-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004405-abs-0002" lang="en"> <h3>Corticosteroids for bacterial meningitis</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effect of corticosteroids on mortality, hearing loss and/or neurological sequelae (such as hearing loss, neurologic deficits) in adults and children with acute bacterial meningitis. </p> <p><b>Background</b> </p> <p>Acute bacterial meningitis is an infection of the meninges (the system of membranes that envelops the brain and spinal cord), which often causes hearing loss. Bacterial meningitis is fatal in 5% to 40% of children and 20% to 50% of adults despite treatment with adequate antibiotics. It is caused by bacteria that usually spread from an ear or respiratory infection and is treated with antibiotics. </p> <p>Corticosteroids are drugs that can reduce the inflammation caused by infection. This inflammation has been shown to aggravate damage to the nervous system in experimental meningitis studies in animals. Research on the use of corticosteroids in addition to antibiotics has had conflicting results. </p> <p>We wanted to discover whether use of corticosteroids was better of worse than placebo.</p> <p><b>Study characteristics</b> </p> <p>The evidence is current to February 2015. We identified 25 trials, including 4121 participants with acute bacterial meningitis of which seven were performed in adults (over 16 years old), two included both children and adults and the other were performed in children. In 22 studies the corticosteroid used was dexamethasone, in three others hydrocortisone or prednisone were used. Nine studies were performed in low‐income countries and 16 in high‐income countries. </p> <p><b>Key results</b> </p> <p>This review found that the corticosteroid dexamethasone did not significantly reduce the death rate (17.8% versus 19.9%). Patients treated with corticosteroids had significantly lower rates of severe hearing loss (6.0% versus 9.3%), any hearing loss (13.8% versus 19.0%) and neurological sequelae (17.9% versus 21.6%). </p> <p>An analysis for different bacteria causing meningitis showed that patients with meningitis due to <i>Streptococcus pneumoniae</i> (<i>S pneumoniae</i> ) treated with corticosteroids had a lower death rate (29.9% versus 36.0%), while no effect on mortality was seen in patients with <i>Haemophilus influenzae</i> (<i>H influenzae</i> ) and <i>Neisseria meningitidis</i> (<i>N meningitidis</i>) meningitis. </p> <p>In high‐income countries, corticosteroids reduced severe hearing loss, any hearing loss and short‐term neurological sequelae. There was no beneficial effect of corticosteroid therapy in low‐income countries. </p> <p>Corticosteroids decreased the rate of hearing loss in children with meningitis due to <i>H influenzae</i> (4% versus 12%), but not in children with meningitis due to other bacteria. </p> <p>Dexamethasone increased the rate of recurrent fever (28% versus 22%) but was not associated with other adverse events. </p> <p><b>Quality of the evidence</b> </p> <p>Out of 25 studies, four were of high quality, 14 of medium quality and seven of low quality, leading to a moderate overall quality of evidence. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004405-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004405-sec-0068"></div> <h3 class="title" id="CD004405-sec-0069">Implications for practice</h3> <section id="CD004405-sec-0069"> <p>In summary, the consistency and degree of benefit identified in this analysis merits the use of corticosteroids in adults and children with acute bacterial meningitis in high‐income countries, although the strength of the evidence is not optimal. We recommend a four‐day regimen of dexamethasone (0.6 mg/kg daily) given before or with the first dose of antibiotics. </p> </section> <h3 class="title" id="CD004405-sec-0070">Implications for research</h3> <section id="CD004405-sec-0070"> <p> <ol id="CD004405-list-0003"> <li> <p>Although additional evidence from well‐designed randomised controlled trials (RCTs) would be optimal, this is impractical for reasons of cost and logistics. </p> </li> <li> <p>Further follow‐up studies in countries where dexamethasone has been implemented may provide additional circumstantial evidence on the effectiveness of adjunctive dexamethasone. </p> </li> <li> <p>The role of corticosteroids in neonatal meningitis is currently unclear due to the different spectrum of causative micro‐organisms and the lack of applicable RCT data. Additional RCTs in neonatal meningitis are needed. </p> </li> <li> <p>Case series are needed to determine the effect of adjunctive dexamethasone therapy in patients with pneumococcal meningitis caused by highly penicillin‐ or cephalosporin‐resistant strains. </p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004405-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004405-sec-0008"></div> <div class="table" id="CD004405-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Comparison of corticosteroids against placebo in patients with acute bacterial meningitis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute bacterial meningitis<br/> <b>Setting:</b> hospitals, low‐ and high‐income countries<br/> <b>Intervention:</b> corticosteroids<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.90<br/> (0.80 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4121<br/> (25 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊖⊖</p> <p>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000<br/> (159 to 201) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/> (150 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Severe hearing loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.67<br/> (0.51 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2437<br/> (17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62 per 1000<br/> (47 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000<br/> (20 to 35) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Any hearing loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.74<br/> (0.63 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2785<br/> (20 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000<br/> (120 to 166) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>233 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1000<br/> (147 to 203) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Short‐term neurological sequelae</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.83<br/> (0.69 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1756<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000<br/> (149 to 216) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>184 per 1000<br/> (153 to 222) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Adverse events ‐ recurrent fever</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.27<br/> (1.09 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1723<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊖⊖<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000<br/> (241 to 326) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>357 per 1000<br/> (307 to 413) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Variable mortality between studies, consistent with differences across the world in meningitis prognosis. </p> <p><sup>2</sup>Different definitions used for recurrent fever makes this imprecise. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004405-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004405-sec-0009"></div> <section id="CD004405-sec-0010"> <h3 class="title" id="CD004405-sec-0010">Description of the condition</h3> <p>Bacterial meningitis is a severe infection of the meninges (the membrane lining of the brain and spinal cord) that is associated with high mortality and morbidity rates despite optimal antibiotic therapy and advances in critical care (<a href="./references#CD004405-bbs2-0044" title="BaraffLJ , LeeSI , SchrigerDL . Outcomes of bacterial meningitis in children: a meta‐analysis. Pediatric Infectious Disease Journal1993;12(5):389‐94. ">Baraff 1993</a>; <a href="./references#CD004405-bbs2-0047" title="BohrV , HansenB , JessenO , JohnsenN , KjersemH , KristensenHS , et al. Eight hundred and seventy‐five cases of bacterial meningitis. Part I of a three‐part series: clinical data, prognosis, and the role of specialised hospital departments. Journal of Infection1983;7(1):21‐30. ">Bohr 1983</a>; <a href="./references#CD004405-bbs2-0050" title="BrouwerMC ,  Tunkel AR ,  van de BeekD . Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews2010;23(3):467‐92. ">Brouwer 2010c</a>; <a href="./references#CD004405-bbs2-0082" title="van deBeekD , SchmandB , DeGansJ , WeisfeltM , VaessenH , DankertJ , et al. Cognitive impairment in adults with good recovery after bacterial meningitis. Journal of Infectious Diseases2002;186(7):1047‐52. ">van de Beek 2002</a>; <a href="./references#CD004405-bbs2-0084" title="van deBeekD , deGansJ , SpanjaardL , WeisfeltM , ReitsmaJB , VermeulenM . Clinical features and prognostic factors in adults with bacterial meningitis. New England Journal of Medicine2004;351(18):1849‐59. ">van de Beek 2004b</a>; <a href="./references#CD004405-bbs2-0086" title="van deBeekD , deGansJ . Dexamethasone in adults with community‐acquired bacterial meningitis. Drugs2006;66(4):415‐27. ">van de Beek 2006b</a>). Late sequelae such as cranial nerve impairment, especially hearing loss, occur in 5% to 40% of patients (<a href="./references#CD004405-bbs2-0044" title="BaraffLJ , LeeSI , SchrigerDL . Outcomes of bacterial meningitis in children: a meta‐analysis. Pediatric Infectious Disease Journal1993;12(5):389‐94. ">Baraff 1993</a>; <a href="./references#CD004405-bbs2-0047" title="BohrV , HansenB , JessenO , JohnsenN , KjersemH , KristensenHS , et al. Eight hundred and seventy‐five cases of bacterial meningitis. Part I of a three‐part series: clinical data, prognosis, and the role of specialised hospital departments. Journal of Infection1983;7(1):21‐30. ">Bohr 1983</a>; <a href="./references#CD004405-bbs2-0049" title="BrouwerMC ,  HeckenbergSG , deGansJ , SpanjaardL , ReitsmaJB , van deBeekD . Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology2010;75(17):1533‐9. ">Brouwer 2010b</a>; <a href="./references#CD004405-bbs2-0058" title="HeckenbergSG , BrouwerMC , van derEndeA , HensenEF , van deBeekD . Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype. Clinical Microbiology and Infection2012;18(9):849‐55. ">Heckenberg 2012a</a>; <a href="./references#CD004405-bbs2-0082" title="van deBeekD , SchmandB , DeGansJ , WeisfeltM , VaessenH , DankertJ , et al. Cognitive impairment in adults with good recovery after bacterial meningitis. Journal of Infectious Diseases2002;186(7):1047‐52. ">van de Beek 2002</a>; <a href="./references#CD004405-bbs2-0084" title="van deBeekD , deGansJ , SpanjaardL , WeisfeltM , ReitsmaJB , VermeulenM . Clinical features and prognostic factors in adults with bacterial meningitis. New England Journal of Medicine2004;351(18):1849‐59. ">van de Beek 2004b</a>; <a href="./references#CD004405-bbs2-0086" title="van deBeekD , deGansJ . Dexamethasone in adults with community‐acquired bacterial meningitis. Drugs2006;66(4):415‐27. ">van de Beek 2006b</a>). </p> </section> <section id="CD004405-sec-0011"> <h3 class="title" id="CD004405-sec-0011">Description of the intervention</h3> <p>Intravenously or orally administered corticosteroids, such as prednisolone, hydrocortisone and dexamethasone, are given before, with or after antibiotic treatment for suspected or proven bacterial meningitis. </p> </section> <section id="CD004405-sec-0012"> <h3 class="title" id="CD004405-sec-0012">How the intervention might work</h3> <p>In experimental animal studies, the outcome of meningitis worsens with increasing severity of the inflammatory process in the subarachnoidal space (<a href="./references#CD004405-bbs2-0078" title="ScheldWM , DaceyRG , WinnHR , WelshJE , JaneJA , SandeMA . Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. Journal of Clinical Investigation1980;66(2):243‐53. ">Scheld 1980</a>; <a href="./references#CD004405-bbs2-0079" title="TauberMG , Khayam‐BashiH , SandeMA . Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. Journal of Infectious Diseases1985;151(3):528‐34. ">Tauber 1985</a>). Treatment with corticosteroids was shown to result in a reduction of the inflammatory response in the cerebrospinal fluid (CSF), reversal of brain oedema and improved outcome (<a href="./references#CD004405-bbs2-0078" title="ScheldWM , DaceyRG , WinnHR , WelshJE , JaneJA , SandeMA . Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. Journal of Clinical Investigation1980;66(2):243‐53. ">Scheld 1980</a>; <a href="./references#CD004405-bbs2-0079" title="TauberMG , Khayam‐BashiH , SandeMA . Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. Journal of Infectious Diseases1985;151(3):528‐34. ">Tauber 1985</a>). These pathophysiological insights prompted investigators to evaluate corticosteroids as an adjuvant therapy in acute bacterial meningitis. </p> </section> <section id="CD004405-sec-0013"> <h3 class="title" id="CD004405-sec-0013">Why it is important to do this review</h3> <p>In the 1960s two randomised controlled trials (RCTs) evaluated the effect of corticosteroids in patients with bacterial meningitis (<a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>). New randomised clinical trials were performed in the late 1980s and 1990s (<a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>), with conflicting results. Two meta‐analyses of RCTs were published showing a reduction in bilateral hearing loss in dexamethasone‐treated children with <i>Haemophilus influenzae</i> (<i>H influenzae</i>) meningitis (<a href="./references#CD004405-bbs2-0055" title="GeimanBJ , SmithAL . Dexamethasone and bacterial meningitis. A meta‐analysis of randomized clinical trials. Western Journal of Medicine1992;157:27‐31. ">Geiman 1992</a>; <a href="./references#CD004405-bbs2-0057" title="HavensPL , WendelbergerKJ , HoffmanGM , LeeMB , ChusidMJ . Corticosteroids as adjunctive therapy in bacterial meningitis. A meta‐analysis of clinical trials. American Journal of Diseases of Children1989;143:1051‐5. ">Havens 1989</a>). </p> <p>In the early 1990s the epidemiology of bacterial meningitis changed due to the introduction of the <i>H influenzae</i> type B conjugate vaccine that resulted in near elimination of this bacterium as cause of meningitis in high‐income countries (<a href="./references#CD004405-bbs2-0071" title="PeltolaH . Worldwide Haemophilus influenzae type B disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews2000;13(2):302‐17. ">Peltola 2000</a>). New trials were performed in children with bacterial meningitis, most commonly caused by <i>Streptococcus pneumoniae</i> (<i>S pneumoniae</i> ). In 1997, a new meta‐analysis was published showing adjunctive corticosteroid therapy to prevent hearing loss in patients with <i>H influenzae</i> meningitis (<a href="./references#CD004405-bbs2-0066" title="McIntyrePB , BerkeyCS , KingSM , SchaadUB , KilpiT , KanraGY , et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta‐analysis of randomized clinical trials since 1988. JAMA1997;278(11):925‐31. ">McIntyre 1997</a>). This meta‐analysis also showed a beneficial trend of dexamethasone on neurological sequelae and hearing loss in patients with meningitis due to <i>S pneumoniae.</i> </p> <p>In the 2000s, five large randomised clinical trials have been performed. Two trials in children were performed in Malawi and South America and three trials in adults were performed in Europe, Vietnam and Malawi (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>). The European trial showed a beneficial effect in all patients, with the most apparent effect on mortality and unfavourable outcomes in pneumococcal meningitis (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>). The Vietnamese trial showed a beneficial effect only in patients with proven bacterial meningitis (<a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>). The other trials did not show a beneficial effect. In 2010 an individual patient data meta‐analysis was performed with patients from these five trials to determine in which subgroups of patients adjunctive dexamethasone was effective (<a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>). In this meta‐analysis no benefit of adjunctive dexamethasone was found in any of the pre‐specified subgroups. However, a post hoc analysis did show a reduction in any hearing loss in surviving patients treated with dexamethasone. </p> <p>The results of many trials have been inconclusive and most studies have been relatively small. Trials have varied greatly in study population, study design, timing and dosage of corticosteroids. Furthermore, mortality was substantially higher in studies in low‐income countries, primarily related to access to care and co‐morbidities. This Cochrane systematic review and meta‐analysis facilitates an interpretation of these varying results and might identify subgroups that benefit from adjunctive corticosteroid therapy. See <a href="./appendices#CD004405-sec-0074">Appendix 1</a> for a glossary of terms. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004405-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004405-sec-0014"></div> <p>To examine the effect of adjuvant corticosteroid therapy versus placebo on mortality, hearing loss and neurological sequelae in people of all ages with acute bacterial meningitis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004405-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004405-sec-0015"></div> <section id="CD004405-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004405-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD004405-sec-0018"> <h4 class="title">Types of participants</h4> <p>Participants of any age and in any clinical condition.</p> </section> <section id="CD004405-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Participants with community‐acquired bacterial meningitis treated with antibacterial agents and randomised to adjuvant corticosteroid therapy of any type. </p> </section> <section id="CD004405-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>At least case‐fatality rate or hearing loss had to be recorded for studies to be included.</p> <section id="CD004405-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004405-list-0001"> <li> <p>Mortality</p> </li> <li> <p>Hearing loss</p> </li> <li> <p>Neurological sequelae</p> </li> </ol> </p> <p>Hearing loss was defined as severe when there was bilateral hearing loss greater than 60 dB or requiring bilateral hearing aids. We analysed any hearing loss and severe hearing loss separately. Neurological sequelae were defined as focal neurological deficits other than hearing loss, epilepsy (not present before meningitis onset), severe ataxia and severe memory or concentration disturbance. We did not count children with isolated speech or language disturbances as having non‐hearing deficits if these problems were associated with severe hearing loss. We analysed both short‐ and long‐term neurological sequelae, other than hearing loss. Short‐term neurological sequelae were defined as sequelae assessed between discharge and six weeks after hospital discharge. Long‐term neurological sequelae were defined as sequelae assessed between six weeks and 12 months after discharge. Whenever possible, we extracted data for both these outcomes. </p> </section> <section id="CD004405-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004405-list-0002"> <li> <p>Adverse events</p> </li> </ol> </p> <p>Adverse events were defined as clinically evident gastrointestinal tract bleeding, reactive arthritis, pericarditis, herpes zoster or herpes simplex virus infection, fungal infection, recurrent fever (defined as a temperature of 38 °C or above occurring after at least one afebrile day during the course of hospitalisation) and persistent fever (defined as fever continuing longer than five consecutive days after initiation of appropriate antibiotic therapy). </p> </section> </section> </section> <section id="CD004405-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004405-sec-0024"> <h4 class="title">Electronic searches</h4> <p>For this 2015 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 1), which includes the Cochrane Acute Respiratory Infections Group Specialised Register, MEDLINE (January 2013 to January Week 4, 2015), Embase (January 2013 to February 2015), Web of Science (January 2013 to February 2015), CINAHL (January 2013 to February 2015) and LILACS (January 2013 to February 2015). Details of earlier searches are in <a href="./appendices#CD004405-sec-0075">Appendix 2</a>. </p> <p>We used the search strategy described in <a href="./appendices#CD004405-sec-0076">Appendix 3</a> to search CENTRAL and MEDLINE. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD004405-bbs2-0064" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We adapted the search strategy to search Embase (<a href="./appendices#CD004405-sec-0077">Appendix 4</a>), Web of Science (<a href="./appendices#CD004405-sec-0078">Appendix 5</a>), CINAHL (<a href="./appendices#CD004405-sec-0079">Appendix 6</a>) and LILACS (<a href="./appendices#CD004405-sec-0080">Appendix 7</a>). We did not apply any language or publication restrictions. </p> </section> <section id="CD004405-sec-0025"> <h4 class="title">Searching other resources</h4> <p>Besides the electronic search we identified relevant trials by searching references listed in published studies, handsearching congress abstracts, personal communication with researchers and experts in the field and from literature lists of pharmaceutical companies. We also searched the trials registries World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov for completed and ongoing trials (June 2015). </p> </section> </section> <section id="CD004405-sec-0026"> <h3 class="title" id="CD004405-sec-0026">Data collection and analysis</h3> <section id="CD004405-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MD, DvdB) independently screened the search results and retrieved the full articles of all potentially relevant trials. We scrutinised each trial report to ensure that multiple publications from the same trial were included only once. We resolved disagreements through discussion and listed the excluded studies and the reasons for their exclusion. </p> </section> <section id="CD004405-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MB, DvdB) independently extracted data according to a pre‐specified protocol. Data extracted included study design, inclusion criteria, patients' characteristics, country in which the study was performed, intervention characteristics and outcome measures. Scored intervention characteristics were corticosteroid type, daily corticosteroid dose, duration of steroid therapy and timing of corticosteroid therapy initiation (before/with the first dose of antibiotic therapy, or after first dose of antibiotic therapy). We resolved disagreements through discussion and contacted the corresponding publication author in the case of unclear or missing data. </p> <p>For dichotomous outcomes, we recorded the number of participants experiencing the event and the number randomised in each treatment group. To allow an available‐case analysis, we recorded the numbers of participants analysed in each treatment group and used them in the analyses. However, we also recorded the number of participants randomised into the treatment arms and used the discrepancy between the figures to calculate the loss to follow‐up. Also, these figures allowed a worst‐case scenario analysis to be carried out to investigate the effect of missing data. </p> </section> <section id="CD004405-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For each study we completed a 'Risk of bias' table, scoring for adequacy of sequence generation, allocation concealment, blinding, if incomplete data were addressed, selective reporting and other sources of bias (<a href="./references#CD004405-bbs2-0060" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell. ">Higgins 2011</a>). We excluded studies without adequate sequence generation from the meta‐analyses. </p> </section> <section id="CD004405-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>All outcome measures were dichotomous. We used risk ratios (RR) with 95% confidence intervals (CI) as measures of treatment effect. </p> </section> <section id="CD004405-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>For studies using multiple treatment groups, we included only groups receiving corticosteroids or placebo in the meta‐analysis. </p> </section> <section id="CD004405-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the corresponding publication author in the case of unclear or missing data. If details were not provided, results used in the analysis were as provided in the publication. </p> <p>We scored missing data in the outcome measures severe hearing loss and neurological sequelae for each study if reported. We assessed whether missing data were equally distributed between treatment and control groups using the Chi<sup>2</sup> test. These tests were two‐tailed and we considered a P value of &lt; 0.05 significant. </p> </section> <section id="CD004405-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity in all analysis with the I<sup>2</sup> statistic with a value of &gt;= 50% taken to indicate statistical heterogeneity. </p> </section> <section id="CD004405-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We conducted visual inspection of the funnel plot of the studies for any obvious asymmetry that could indicate publication bias. </p> </section> <section id="CD004405-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using Review Manager 5.3 (<a href="./references#CD004405-bbs2-0075" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We performed meta‐analyses using the Mantel‐Haenszel method with a fixed‐effect model when heterogeneity was absent. When significant heterogeneity was established we used a random‐effects model. </p> </section> <section id="CD004405-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses for children and adults, causative organisms, low‐income versus high‐income countries, time of administration of steroids and quality of studies. Two age groups were defined: patients younger than 16 years and those aged 16 years and older. Three categories of causative organisms were defined: <i>H influenzae</i> ,<i>Neisseria meningitidis</i> (<i>N meningitidis</i> ) and<i>S pneumoniae</i>. We analysed studies in two subsets divided into low‐income and high‐income countries. Low‐income countries had a United Nations Human Development Index of less than 0.7 and high‐income countries had an index of 0.7 or higher (<a href="./references#CD004405-bbs2-0081" title="United Nations Human Development Index. Human Development Index. http://hdr.undp.org/en/statistics/ 2009 (accessed 25 November 2009). ">UNHDI 2009</a>). Studies were divided into three categories of methodological quality: high, medium and low according to the score in the 'Risk of bias' table. If all questions in the 'Risk of bias' table were answered positively we categorised the study as high quality, three through five as medium quality and less than three questions answered positively as low quality. </p> <p>In the subgroup analysis we used the inverse variance method with a fixed‐effect model to detect significant heterogeneity between subgroups, using a P value of &lt; 0.05 and I<sup>2</sup> statistic =&gt; 50%. </p> </section> <section id="CD004405-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>For trials with missing data, we conducted two analyses: an available‐case analysis and a worst‐case scenario analysis. We considered all participants who had dropped out of the corticosteroid group to have an unfavourable outcome whereas we considered those who had dropped out of the control group to have a favourable outcome. We conducted a sensitivity analysis by imputing the missing data in this way to determine whether the overall results were sensitive to this assumption. </p> <p>We performed additional random‐effects model analyses for all studies without significant heterogeneity determined by the I<sup>2</sup> statistic (I<sup>2</sup> statistic &lt; 50%) to see if results were valid with this method as well. </p> <p>Finally, we performed the analyses for the primary outcome measures without studies with unclear or unknown sequence generation. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004405-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004405-sec-0038"></div> <section id="CD004405-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD004405-sec-0040"> <h4 class="title">Results of the search</h4> <p>Since the first publication of this review we have retrieved a total of 4421 records. After removing duplicates we identified 3559 records in the electronic databases. </p> <p>In the previous publications of this review, <a href="./references#CD004405-bbs2-0093" title="BrouwerMC , McIntyreP , PrasadK , van deBeekD . Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD004405.pub4] ">Brouwer 2013</a>, we identified 40 potentially eligible trials, of which two were described in one paper (<a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>). Two papers presented data from one study (<a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0039" title="SinghiS , JärvinenA , PeltolaH . Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatric Infectious Disease Journal2008;27:892‐6. ">Singhi 2008</a>). In this 2015 search we did not identify any new trials for inclusion. </p> </section> <section id="CD004405-sec-0041"> <h4 class="title">Included studies</h4> <p>A total of 25 studies were eligible for inclusion in the meta‐analysis (<a href="./references#CD004405-sec-0107" title="">Characteristics of included studies</a>). These studies included 4121 patients (2064 dexamethasone, 2057 placebo). Participants over 16 years were included in seven studies (1517 patients: 756 dexamethasone, 761 placebo) (<a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>). In two studies, participants older than 12 years were considered adults (<a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>). The study intervention consisted of dexamethasone in 22 out of 25 studies; dosages ranged from 0.4 to 1.5 mg/kg/d and duration ranged from two to four days. In the other studies hydrocortisone, prednisolone or a combination of both were given and duration ranged from three to 14 days (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>). </p> <p>Study medication was administered before or with the first dose of antibiotics in 13 studies, and after the first dose in eight studies. In four studies the time of administration was not stated. </p> <p>A sample size calculation was given in eight studies (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>). </p> <p>Mortality rates ranged from 0% to 54%. In one study participants who died during the first 18 hours of admission were excluded (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>); nevertheless, we included these participants in the meta‐analysis. Hearing was assessed by audiometry in seven studies in children and four studies in adults; other studies used brainstem evoked potentials (10) or age‐specific behavioural measures (eight). Four studies assessed both short‐term and long‐term neurological sequelae (<a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>). Definitions of adverse events were heterogeneous and we recalculated the number of events for each study. </p> <p>Ethical review by hospital committees was described in 18 (72%) studies. Eighteen (72%) studies described informed consent procedures. There were no disagreements on inclusion or exclusion of studies between the review authors extracting study data. No study authors needed to be contacted to provide additional information for this updated version of the review. </p> <p>Ten studies were funded in part by pharmaceutical companies, which were often only providing study medication. Five studies were funded by charities, four by government funding organisations, and funding was not reported for nine studies. </p> </section> <section id="CD004405-sec-0042"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 trials (<a href="./references#CD004405-sec-0108" title="">Characteristics of excluded studies</a>). Three studies did not randomise between treatment and control groups (<a href="./references#CD004405-bbs2-0034" title="MarguetC , MalletE . Value of dexamethasone in purulent meningitis in children. Apropos of a comparative study of 85 children. Archives Français Pediatrie1993;50(2):111‐7. ">Marguet 1993</a>; <a href="./references#CD004405-bbs2-0035" title="OzenM , KanraG , KaraA , BakarEE , CeyhanM , SecmeerG , et al. Long‐term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis. Scandinavian Journal of Infectious Diseases2006;38(2):104‐9. ">Ozen 2006</a>; <a href="./references#CD004405-bbs2-0041" title="Tolaj I ,  DreshajS ,  QehajaE ,  Tolaj J ,  Doda‐EjupiT ,  MehmetiM . Dexamethasone as adjuvant therapy in the treatment of invasive meningococcal diseases. Medicinski Arhiv2010;64(4):228‐30. ">Tolaj 2010</a>). Nine trials did not adequately generate a randomisation sequence and in most of these alternate allocation schemes were used (<a href="./references#CD004405-bbs2-0026" title="AyazC , CelenMK , GeyikMF , UlugM . The efficacy of dexamethasone treatment in adult patients with acute bacterial meningitis. Neurosciences2008;13:146‐50. ">Ayaz 2008</a>; <a href="./references#CD004405-bbs2-0027" title="BaldyJL , PassosJN . Dexamethasone in the treatment of meningococcal meningitis. Revista Paulista de Medicina1986;104(2):61‐5. ">Baldy 1986</a>; <a href="./references#CD004405-bbs2-0028" title="DaoudAS , BatiehaA , Al‐SheyyabM , AbuekteishF , ObeidatA , MahafzaT . Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. European Journal of Pediatrics1999;158(3):230‐3. ">Daoud 1999</a>; <a href="./references#CD004405-bbs2-0030" title="GijwaniD , KumharMR , SinghVB , ChaddaVS , SoniPK , NayakKC , et al. Dexamethasone therapy for bacterial meningitis in adults: a double blind placebo control study. Neurology India2002;50(1):63‐7. ">Gijwani 2002</a>; <a href="./references#CD004405-bbs2-0031" title="GuptaA , SinghNK . Dexamethasone in adults with bacterial meningitis. Journal of the Association of Physicians of India1996;44(2):90‐2. ">Gupta 1996</a>; <a href="./references#CD004405-bbs2-0032" title="JensenK , RanekL , RosdahlN . Bacterial meningitis; a review of 356 cases with special reference to corticosteroid and antiserum treatment. Scandinavian Journal of Infectious Diseases1969;1(1):21‐30. ">Jensen 1969</a>; <a href="./references#CD004405-bbs2-0033" title="LepperM , SpiesHW . Treatment of pneumococcic meningitis. Archives of Internal Medicine1959;104(3):253‐9. ">Lepper 1959</a>; <a href="./references#CD004405-bbs2-0036" title="PassosJN , BaldyJL . Evaluation of the use of dexamethasone in the therapeutic schedule for purulent meningitis. Revista do Instituto de Medicina Tropical de São Paulo1979;21(2):90‐8. ">Passos 1979</a>; <a href="./references#CD004405-bbs2-0038" title="ShembeshNM , ElbargathySM , KashburIM , RaoBN , MahmoudKS . Dexamethasone as an adjunctive treatment of bacterial meningitis. Indian Journal of Pediatrics1997;64(4):517‐22. ">Shembesh 1997</a>). One study compared two dexamethasone regimens (<a href="./references#CD004405-bbs2-0040" title="SyrogiannopoulosGA , LouridaAN , TheodoridouMC , PappasIG , Babilis , GC , EconomidisJJ , et al. Dexamethasone therapy for bacterial meningitis in children: 2‐ versus 4‐day regimen. Journal of Infectious Diseases1994;169(4):853‐8. ">Syrogiannopoulos 1994</a>), one was a duplicate study (<a href="./references#CD004405-bbs2-0039" title="SinghiS , JärvinenA , PeltolaH . Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatric Infectious Disease Journal2008;27:892‐6. ">Singhi 2008</a>), and one study provided insufficient data (communications during scientific meetings only) (<a href="./references#CD004405-bbs2-0029" title="FarinaJSL , AlencastroR , DallignaC , RottaNT . Dexamethasone and bacterial meningitis: a randomised controlled trial in Brazilian children and a meta‐analysis study. Neurology1995;45(A349):45. ">Farina 1995</a>). </p> </section> </section> <section id="CD004405-sec-0043"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD004405-sec-0044"> <h4 class="title">Summary of general risk of bias</h4> <p>Four of 25 studies were free of bias, whereas the other 21 had one or more biases. Attrition, reporting and potential selection bias were most common, occurring in eight, 18 and 12 studies (<a href="#CD004405-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD004405-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD004405-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> </section> <section id="CD004405-sec-0045"> <h4 class="title">Allocation</h4> <p>The sequence generation for participant allocation was adequate in 20 studies. In five studies the method of sequence generation was unclear or not specified (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>) (<a href="#CD004405-fig-0002">Figure 2</a>; <a href="#CD004405-fig-0001">Figure 1</a>). In five studies the treatment allocation was not concealed (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>), and in one study treatment allocation concealment was unclear as participants were paired for placebo or dexamethasone (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>). A multicentre study performed in several South American countries compared two treatments in a 2 x 2 design, dexamethasone and glycerol with placebo, in four randomisation arms (glycerol‐dexamethasone, glycerol‐placebo, dexamethasone‐placebo, placebo‐placebo). However, some centres did not include participants in the double placebo group, thereby disturbing the allocation concealment (<a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>). Data were extracted as derived from one study, comparing the dexamethasone‐placebo versus placebo‐placebo groups. </p> <div class="figure" id="CD004405-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD004405-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD004405-sec-0046"> <h4 class="title">Blinding</h4> <p>Nineteen studies had a double‐blind design and broke the treatment code after follow‐up for the last participant was complete. Six studies did not use blinding (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>). </p> </section> <section id="CD004405-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>Missing data were addressed in 16 studies and were not addressed in eight (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>). One study reported having complete data for all included participants (<a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>). Out of 2694 survivors who were included in studies that analysed severe hearing loss, 216 (8.0%) were not tested or had inconclusive test results. Data on any hearing loss were missing in 223 of 3029 (7.4%) surviving participants included in studies that assessed hearing loss. Short‐term neurological sequelae were assessed in 1695 of 1850 survivors included in studies that scored short‐term sequelae; data on 155 (8.3%) were missing. Data on long‐term sequelae were missing in 157 of 1705 participants (9.2%). The number of missing data was equally distributed between treatment and control group (P value for differences in missing data &gt; 0.10 for all analyses with missing data). </p> </section> <section id="CD004405-sec-0048"> <h4 class="title">Selective reporting</h4> <p>An intention‐to‐treat (ITT) analysis was performed in six studies (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>), comprising 2147 out of 4041 participants (53%). One study that reported no loss to follow‐up or discontinuing treatment was analysed as ITT (<a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>). In the other 18 studies only per‐protocol data were available to be ascertained. The final analysis for mortality is equally based upon per‐protocol figures (46% of included participants) and ITT figures (56%). </p> <p>A study protocol with pre‐specification of the analyses had not been published prior to publication of the complete study results for any of the included studies. None of the trials registered a study protocol in a trial registry. </p> <p>Funnel plots of outcomes (mortality, any hearing loss, short‐term neurological sequelae and long‐term neurological sequelae and adverse events) did not show obvious asymmetry, except for severe hearing loss (<a href="./references#CD004405-fig-0007" title="">Analysis 1.1</a>; <a href="./references#CD004405-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD004405-fig-0009" title="">Analysis 1.3</a>; <a href="./references#CD004405-fig-0010" title="">Analysis 1.4</a>; <a href="./references#CD004405-fig-0011" title="">Analysis 1.5</a>; <a href="./references#CD004405-fig-0012" title="">Analysis 1.6</a>). </p> </section> <section id="CD004405-sec-0049"> <h4 class="title">Other potential sources of bias</h4> <p>In 12 studies differences in baseline and clinical characteristics between treatment and control groups influenced comparability of groups (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>), indicating either insufficient sample size to equal out the random differences between randomisation arms or a selection bias. We found other indications of a selection bias in studies with high numbers of comatose participants or low numbers of culture‐positive participants (<a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>). Nine studies did not present sufficient participant characteristics to determine whether the participants in each randomisation arm were comparable. </p> </section> </section> <section id="CD004405-sec-0050"> <h3 class="title" id="CD004405-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD004405-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings table</a> </p> <section id="CD004405-sec-0051"> <h4 class="title">Primary outcomes</h4> <section id="CD004405-sec-0052"> <h5 class="title">1. Mortality</h5> <p>A lower overall number of deaths in the corticosteroid‐treated group was observed compared to the placebo group (367 of 2064 (17.8%) versus 408 out of 2057 (19.8%), risk ratio (RR) 0.90, 95% confidence interval (CI) 0.80 to 1.01, P value = 0.07), although the difference did not reach statistical significance (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) (<a href="./references#CD004405-fig-0007" title="">Analysis 1.1</a>; <a href="#CD004405-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD004405-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All patients, outcome: 1.1 Mortality." data-id="CD004405-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.1 Mortality.</p> </div> </div> </div> </section> <section id="CD004405-sec-0053"> <h5 class="title">2. Hearing loss</h5> <p>The number of participants with hearing loss was significantly smaller in the corticosteroid‐treated group than in the placebo group (any hearing loss: 197 of 1424 (14%) versus 259 of 1361 (19%), RR 0.74, 95% CI 0.63 to 0.87; severe hearing loss: 75 of 1234 (6%) versus 112 of 1203 (9%), RR 0.67, 95% CI 0.51 to 0.88) (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) (<a href="./references#CD004405-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD004405-fig-0009" title="">Analysis 1.3</a>; <a href="#CD004405-fig-0004">Figure 4</a>; <a href="#CD004405-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD004405-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All patients, outcome: 1.2 Severe hearing loss." data-id="CD004405-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.2 Severe hearing loss.</p> </div> </div> </div> <div class="figure" id="CD004405-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All patients, outcome: 1.3 Any hearing loss." data-id="CD004405-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.3 Any hearing loss.</p> </div> </div> </div> </section> <section id="CD004405-sec-0054"> <h5 class="title">3. Neurological sequelae</h5> <p>Short‐term neurologic sequelae (excluding hearing loss) were assessed in 13 studies including 1756 participants (<a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) (<a href="./references#CD004405-fig-0010" title="">Analysis 1.4</a>). Fewer sequelae were observed in the corticosteroid‐treated group (161 of 900 (17.9%) versus 185 of 856 (21.6%), RR 0.83, 95% CI 0.69 to 1.00, P value = 0.05). Long‐term neurological sequelae were assessed in 12 studies including 1652 participants (<a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) (<a href="./references#CD004405-fig-0011" title="">Analysis 1.5</a>). The occurrence of long‐term sequelae was not significantly different between the corticosteroid‐treated participants and the controls (125 of 836 (15.3%) versus 136 of 816 (16.7%), RR 0.90, 95% CI 0.74 to 1.10) (<a href="./references#CD004405-fig-0011" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD004405-sec-0055"> <h4 class="title">Secondary outcome</h4> <section id="CD004405-sec-0056"> <h5 class="title">1. Adverse events</h5> <p>Adverse events were recorded in 20 studies: 16 evaluated gastrointestinal haemorrhage, 12 recurrent fever, six reactive arthritis, five herpes zoster, three persistent fever and one fungal infections (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) (<a href="./references#CD004405-fig-0012" title="">Analysis 1.6</a>; <a href="#CD004405-fig-0006">Figure 6</a>). Participants treated with corticosteroids had an increase in recurrent fever (RR 1.27, 95% CI 1.09 to 1.47). The rate of persistent fever was lower in the corticosteroid‐treated patients (RR 0.29, 95% CI 0.12 to 0.70). Other complications occurred in similar proportions of the treatment and control groups. </p> <div class="figure" id="CD004405-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All patients, outcome: 1.6 Adverse events." data-id="CD004405-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.6 Adverse events.</p> </div> </div> </div> </section> </section> <section id="CD004405-sec-0057"> <h4 class="title">Subgroup analysis</h4> <p>One hundred and sixty‐seven children out of 1269 (13.1%) in the corticosteroid‐treated group died, compared to 182 of 1242 (14.7%) in the placebo group (RR 0.89, 95% CI 0.74 to 1.07) (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>) (<a href="./references#CD004405-fig-0013" title="">Analysis 2.1</a>). </p> <p>Corticosteroids prevented hearing loss in children: any hearing loss was found in 146 of 1001 (14.6%) corticosteroid‐treated participants, compared to 196 of 960 (20.4%) in the control group (RR 0.73, 95% CI 0.61 to 0.86); severe hearing loss was found in 57 of 772 (7.3%) corticosteroid‐treated participants, compared to 86 of 752 (11.2%) in the control group (RR 0.67, 95% CI 0.49 to 0.91) (<a href="./references#CD004405-fig-0015" title="">Analysis 2.3</a>; <a href="./references#CD004405-fig-0014" title="">Analysis 2.2</a>). </p> <p>For adults, study results on mortality were significantly heterogeneous (I<sup>2</sup> statistic = 54%). Using the random‐effects model there was a non‐significant reduction in mortality rate: 187 of 756 (24.7%) died in the corticosteroid‐treated group versus 215 of 761 (28.3%; RR 0.74, 95% CI 0.53 to 1.05; P = 0.09) (<a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>) (<a href="./references#CD004405-fig-0016" title="">Analysis 3.1</a>). The rate of hearing loss in adults was lower in corticosteroid‐treated participants as compared to controls (68 of 433 (15.7%) versus 90 of 411 (21.9%), RR 0.74, 95% CI 0.56 to 0.98; <a href="./references#CD004405-fig-0017" title="">Analysis 3.2</a>). There was a non‐significant reduction in short‐term neurologic sequelae in the corticosteroid‐treated group (RR 0.72, 95% CI 0.51 to 1.01; P = 0.06; <a href="./references#CD004405-fig-0018" title="">Analysis 3.3</a>). </p> <p>Case‐fatality rate varied according to causative micro‐organism (<a href="./references#CD004405-fig-0019" title="">Analysis 4.1</a>). Out of 825 participants with <i>H influenzae</i> meningitis, 87 died (10.5%); compared to 371 of 1132 (32.8%) participants with pneumococcal meningitis and 27 of 620 (4.3%) participants with meningococcal meningitis. Corticosteroids protected against death in pneumococcal meningitis (RR 0.84, 95% CI 0.72 to 0.98) (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>). In meningococcal meningitis, corticosteroids were associated with a non‐significant reduction in mortality (RR 0.71, 95% CI 0.35 to 1.46). For children with meningitis caused by <i>H influenzae</i>, hearing loss was significantly reduced by corticosteroids (RR 0.34, 95% CI 0.20 to 0.59; <a href="./references#CD004405-fig-0021" title="">Analysis 4.3</a>). For children with meningitis caused by bacteria other than <i>H influenzae</i>, no significant beneficial effect was seen (RR 0.95, 95% CI 0.65 to 1.39; <a href="./references#CD004405-fig-0020" title="">Analysis 4.2</a>). </p> <p>We analysed studies in two subsets divided into high‐income (<a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>) and low‐income countries (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>). </p> <p>The risk ratio for mortality in high‐income countries was 0.81 (95% CI 0.63 to 1.05, P = 0.10) in corticosteroid‐treated participants and 0.87 (95% CI 0.67 to 1.15; random‐effects model; I<sup>2</sup> statistic 55%; <a href="./references#CD004405-fig-0022" title="">Analysis 5.1</a>) in low‐income countries, with no heterogeneity between subgroups. </p> <p>In high‐income countries the rates of severe hearing loss (RR 0.51, 95% CI 0.35 to 0.73; <a href="./references#CD004405-fig-0023" title="">Analysis 5.2</a>), any hearing loss (RR 0.58, 95% CI 0.45 to 0.73; <a href="./references#CD004405-fig-0024" title="">Analysis 5.3</a>) and short‐term neurologic sequelae (RR 0.64, 95% CI 0.48 to 0.85; <a href="./references#CD004405-fig-0025" title="">Analysis 5.4</a>) were lower in corticosteroid‐treated participants and showed significant heterogeneity with rates in the low‐income subgroup (severe hearing loss RR 0.99, 95% CI 0.72 to 1.38, I<sup>2</sup> statistic for subgroups 86%; any hearing loss RR 0.89, 95% CI 0.76 to 1.04, I<sup>2</sup> statistic 89%; short‐term neurological sequelae RR 1.03, 95% CI 0.81 to 1.31, I<sup>2</sup> statistic 84%). Subgroup analysis for children in high‐income countries showed a decrease in risk of severe hearing loss and neurologic sequelae in the corticosteroid group (severe hearing loss, RR 0.52, 95% CI 0.35 to 0.78; short‐term sequelae, RR 0.67, 95% CI 0.46 to 0.97), whereas no difference was seen in low‐income countries (severe hearing loss, RR 1.00, 95% CI 0.69 to 1.47, I<sup>2</sup> statistic for subgroups 81%; short‐term sequelae, RR 1.08, 95% CI 0.81 to 1.43, I<sup>2</sup> statistic for subgroups 75%) (<a href="./references#CD004405-fig-0026" title="">Analysis 5.5</a>; <a href="./references#CD004405-fig-0027" title="">Analysis 5.6</a>; <a href="./references#CD004405-fig-0028" title="">Analysis 5.7</a>; <a href="./references#CD004405-fig-0029" title="">Analysis 5.8</a>). For adults in high‐income countries, no significant heterogeneity between subgroups was found (<a href="./references#CD004405-fig-0030" title="">Analysis 5.9</a>; <a href="./references#CD004405-fig-0031" title="">Analysis 5.10</a>). </p> <p>Subgroup analysis on timing of corticosteroids (before or with the first dose of antibiotics versus after the first dose of antibiotics) showed similar results for mortality (RR 0.87 95% CI 0.69 to 1.09 (I<sup>2</sup> statistic 52%, random‐effects model); RR 0.83, 95% CI 0.55 to 1.26) (<a href="./references#CD004405-fig-0032" title="">Analysis 6.1</a>; <a href="./references#CD004405-fig-0033" title="">Analysis 6.2</a>; <a href="./references#CD004405-fig-0034" title="">Analysis 6.3</a>; <a href="./references#CD004405-fig-0035" title="">Analysis 6.4</a>). For subgroup analyses of severe hearing loss and short‐term neurological sequelae, administration after the first dose of antibiotics had slightly more favourable point estimates than studies with early administration of corticosteroids, but there was no significant heterogeneity between subgroups. </p> <p>We analysed studies in three categories of study quality according to the studies' 'Risk of bias' score (<a href="#CD004405-fig-0001">Figure 1</a>). Four studies including 1793 participants were categorised as high quality (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>), 14 studies with 1477 participants as medium quality (<a href="./references#CD004405-bbs2-0007" title="DeLemosRA , HaggertyRJ . Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics1969;44(1):30‐4. ">DeLemos 1969</a>; <a href="./references#CD004405-bbs2-0009" title="KanraGY , OzenH , SecmeerG , CeyhanM , EcevitZ , BelginE . Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatric Infectious Disease Journal1995;14(6):490‐4. ">Kanra 1995</a>; <a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0012" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988a</a>; <a href="./references#CD004405-bbs2-0013" title="LebelMH , FreijBJ , SyrogiannopoulosGA , ChraneDF , HoytMJ , StewartSM , et al. Dexamethasone therapy for bacterial meningitis. Results of two double‐blind, placebo‐controlled trials. New England Journal of Medicine1988;319(15):964‐71. ">Lebel 1988b</a>; <a href="./references#CD004405-bbs2-0014" title="LebelMH , HoytMJ , WaagnerDC , RollinsNK , FinitzoT , McCrackenGHJr , et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. American Journal of Diseases of Children1989;143(3):301‐6. ">Lebel 1989</a>; <a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>; <a href="./references#CD004405-bbs2-0018" title="OdioCM , FaingezichtI , ParisM , NassarM , BaltodanoA , RogersJ , et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine1991;324(22):1525‐31. ">Odio 1991</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0021" title="SankarJ , SinghiP , BansalA , RayP , SinghiS . Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics2007;44:649‐56. ">Sankar 2007</a>; <a href="./references#CD004405-bbs2-0023" title="SchaadUB , LipsU , GnehmHE , BlumbergA , HeinzerI , WedgwoodJ . Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet1993;342(8869):457‐61. ">Schaad 1993</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>; <a href="./references#CD004405-bbs2-0025" title="WaldER , KaplanSL , MasonEOJ , SaboD , RossL , ArditiM , et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics1995;95(1):21‐8. ">Wald 1995</a>), and seven studies including 851 participants as low quality (<a href="./references#CD004405-bbs2-0001" title="BademosiO , OsuntokunBO . Prednisolone in the treatment of pneumococcal meningitis. Tropical and Geographical Medicine1979;31(1):53‐6. ">Bademosi 1979</a>; <a href="./references#CD004405-bbs2-0002" title="BelseyMA , HoffpauirCW , SmithMH . Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics1969;44(4):503‐13. ">Belsey 1969</a>; <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a>; <a href="./references#CD004405-bbs2-0005" title="CianaG , ParmarN , AntonioC , PivettaS , TamburliniG , CuttiniM . Effectiveness of adjunctive treatment with steroids in reducing short‐term mortality in a high‐risk population of children with bacterial meningitis. Journal of Tropical Pediatrics1995;41(3):164‐8. ">Ciana 1995</a>; <a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>; <a href="./references#CD004405-bbs2-0010" title="KilpiT , PeltolaH , JauhiainenT , KallioMJ . Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal1995;14(4):270‐8. ">Kilpi 1995</a>). No significant heterogeneity was found between subgroups of study quality for mortality, any hearing loss and short‐term neurological sequelae (<a href="./references#CD004405-fig-0036" title="">Analysis 7.1</a>; <a href="./references#CD004405-fig-0038" title="">Analysis 7.3</a>; <a href="./references#CD004405-fig-0039" title="">Analysis 7.4</a>). Severe hearing loss was reduced in studies of medium quality (RR 0.47, 95% 0.29 to 0.75; <a href="./references#CD004405-fig-0037" title="">Analysis 7.2</a>), but not in studies of high and low quality, with significant heterogeneity between subgroups (I<sup>2</sup> statistic for subgroups 70%). </p> </section> <section id="CD004405-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>In the worst‐case scenario analyses where participants with missing data on severe hearing loss or any hearing loss in the corticosteroid groups were considered to have an unfavourable outcome, corticosteroids had no effect on severe or any hearing loss (<a href="./references#CD004405-fig-0040" title="">Analysis 8.1</a>; <a href="./references#CD004405-fig-0041" title="">Analysis 8.2</a>). In these analyses, studies were significantly heterogeneous and therefore we used the random‐effects model. One study provided 46% of missing values in the severe hearing loss analysis and 45% of missing values in the analysis on any hearing loss (<a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>). The worst‐case scenario for short‐term and long‐term neurological sequelae showed no beneficial effect of corticosteroids (<a href="./references#CD004405-fig-0042" title="">Analysis 8.3</a>; <a href="./references#CD004405-fig-0043" title="">Analysis 8.4</a>). None of the worst‐case scenarios showed evidence of harm with corticosteroid therapy. </p> <p>Using the random‐effects model in analyses with no significant heterogeneity, the beneficial effect effects of corticosteroids remained significant in <a href="./references#CD004405-fig-0008" title="">Analysis 1.2</a>, <a href="./references#CD004405-fig-0009" title="">Analysis 1.3</a>, <a href="./references#CD004405-fig-0012" title="">Analysis 1.6</a>, <a href="./references#CD004405-fig-0014" title="">Analysis 2.2</a>, <a href="./references#CD004405-fig-0015" title="">Analysis 2.3</a>, <a href="./references#CD004405-fig-0017" title="">Analysis 3.2</a>, <a href="./references#CD004405-fig-0021" title="">Analysis 4.3</a>, <a href="./references#CD004405-fig-0023" title="">Analysis 5.2</a>, <a href="./references#CD004405-fig-0024" title="">Analysis 5.3</a>, <a href="./references#CD004405-fig-0025" title="">Analysis 5.4</a>, <a href="./references#CD004405-fig-0027" title="">Analysis 5.6</a>, <a href="./references#CD004405-fig-0028" title="">Analysis 5.7</a>, <a href="./references#CD004405-fig-0034" title="">Analysis 6.3</a> and <a href="./references#CD004405-fig-0037" title="">Analysis 7.2</a>. The decrease in short‐term neurological sequelae did not remain significant with the random‐effects model, but did show a trend towards benefit (RR 0.83, 95% CI 0.69 to 1.00; P = 0.05). The beneficial effect of corticosteroids on mortality in pneumococcal meningitis found with the fixed‐effect model did not remain significant in the random‐effects model (RR 0.81, 95% CI 0.61 to 1.08; P = 0.16; <a href="./references#CD004405-fig-0019" title="">Analysis 4.1</a>). </p> <p>The sensitivity analyses of studies with adequate sequence generation only showed that the decrease in short‐term neurological sequelae did not remain significant (RR 0.83, 95% CI 0.69 to 1.01). Results for other primary outcome measures did not differ from the initial analyses. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004405-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004405-sec-0059"></div> <section id="CD004405-sec-0060"> <h3 class="title" id="CD004405-sec-0060">Summary of main results</h3> <p>This meta‐analysis showed a beneficial effect of adjunctive corticosteroids in acute bacterial meningitis. Overall, corticosteroids significantly reduced the rate of hearing loss (risk ratio (RR) 0.74, 95% confidence interval (CI) 0.63 to 0.87), severe hearing loss (RR 0.67, 95% CI 0.51 to 0.88) and short‐term neurological sequelae (RR 0.83, 95% CI 0.69 to 1.00). The use of adjunctive corticosteroids was associated with a non‐significant decrease in mortality (RR 0.90, 95% CI 0.80 to 1.01). Use of adjunctive corticosteroids was not associated with a decrease in long‐term neurological sequelae (RR 0.90, 95% CI 0.74 to 1.10). Recurrent fever occurred more often in corticosteroid‐treated participants (RR 1.27, 95% CI 1.09 to 1.47), but other adverse events were found in similar proportions of the treatment and control group. </p> <p>Subgroup analyses for age showed that in children with bacterial meningitis, corticosteroids prevented severe hearing loss (RR 0.67, 95% CI 0.49 to 0.91) and any hearing loss (RR 0.73, 95% CI 0.61 to 0.86). In adults, the rate of any hearing loss was lower in the corticosteroid‐treated group (RR 0.74, 95% CI 0.56 to 0.98); there was a non‐significant reduction in mortality in adults receiving corticosteroids (RR 0.74, 95% CI 0.53 to 1.05, P value = 0.09). </p> <p>Subgroup analysis for causative organism showed that corticosteroids reduce severe hearing loss in children with meningitis due to <i>H influenzae</i> (RR 0.34, 95% CI 0.20 to 0.59), while no effect of corticosteroids on hearing loss was observed in children with non‐<i>Haemophilus</i> meningitis. Subgroup analysis on <i>S pneumoniae</i> showed a favourable effect of corticosteroids on mortality (RR 0.84, 95% CI 0.72 to 0.98). A non‐significant reduction in mortality was found in the <i>N. meningitidis</i> meningitis subgroup (RR 0.71, 95% CI 0.35 to 1.46). No effect on mortality was shown in <i>H influenzae</i> meningitis. </p> <p>Subgroup analysis for high‐income and low‐income countries showed no significant effect on mortality for corticosteroid‐treated participants in high‐income and low‐income countries overall. Corticosteroids were protective against severe hearing loss (RR 0.51, 95% CI 0.35 to 0.73), any hearing loss (RR 0.58, 95% CI 0.45 to 0.73) and short‐term neurological sequelae (RR 0.64, 95% CI 0.48 to 0.85) in high‐income countries, with significant heterogeneity between subgroups. For children in high‐income countries, corticosteroids showed a protective effect against severe hearing loss (RR 0.52, 95% CI 0.35 to 0.78) and short‐term neurological sequelae (RR 0.67, 95% CI 0.46 to 0.97). No effect was observed in low‐income countries. </p> <p>The sensitivity analyses showed that corticosteroids would have no effect on severe or any hearing loss and short‐ or long‐term neurological sequelae if all missing data were imputed as unfavourable events in the corticosteroid‐treated participants. Corticosteroids were not associated with harm in this worst‐case scenario. Further sensitivity analyses showed that the effect of corticosteroids on overall short‐term neurological sequelae and mortality in pneumococcal meningitis would not be significant if the random‐effects model was used. The beneficial effect on short‐term neurological sequelae changed to a trend towards benefit if only studies with adequate sequence generation were included. </p> </section> <section id="CD004405-sec-0061"> <h3 class="title" id="CD004405-sec-0061">Overall completeness and applicability of evidence</h3> <section id="CD004405-sec-0062"> <h4 class="title">Overall completeness</h4> <p>The available studies do not address four important issues ‐ the minimum duration of corticosteroid therapy, type of corticosteroids, the maximum length of time after parenteral antibiotic therapy for commencement of corticosteroid therapy and long‐term effect of corticosteroid therapy. In most studies, a four‐day regimen of dexamethasone (0.4 or 0.6 mg/kg/day) divided into four daily doses was used. One randomised, prospective study involving 118 children with bacterial meningitis showed a two‐day and four‐day regimen of dexamethasone to be similarly effective (<a href="./references#CD004405-bbs2-0040" title="SyrogiannopoulosGA , LouridaAN , TheodoridouMC , PappasIG , Babilis , GC , EconomidisJJ , et al. Dexamethasone therapy for bacterial meningitis in children: 2‐ versus 4‐day regimen. Journal of Infectious Diseases1994;169(4):853‐8. ">Syrogiannopoulos 1994</a>). In this study physicians were not blinded to the treatment groups. Long‐term neurological sequelae, or moderate hearing impairment (or both), were found in 1.8% and 3.8% of patients treated with dexamethasone for two and four days, respectively. It is unlikely that a randomised controlled trial (RCT) will be performed to answer the question of whether a two‐day or four‐day regimen should be used in bacterial meningitis; such a clinical trial would need a very large number of patients enrolled to detect significant differences between groups. Since most studies used a four‐day regimen (without increase of side effects) we advise the use of the four‐day corticosteroid therapy. </p> <p>Three studies used hydrocortisone and/or prednisolone; all others used dexamethasone. Clinical efficacy depends on glucocorticoid pharmacokinetics and pharmacodynamics; of glucocorticoids, dexamethasone has superior penetration in the cerebrospinal fluid (CSF) and a longer half life (<a href="./references#CD004405-bbs2-0043" title="BalisFM , LesterCM , ChrousosGP , HeidemanRL , PoplackDG . Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. Journal of Clinical Oncology1987;5:202‐7. ">Balis 1987</a>). Therefore, dexamethasone is considered to be the corticosteroid of choice in bacterial meningitis. </p> <p>Subgroup analyses for timing of corticosteroids (before or with the first dose of antibiotics versus after the first dose of antibiotic) showed no differences in efficacy of corticosteroids. In previous reports, administration of corticosteroids before or with the first dose of parenteral antibiotics seemed to be more effective than administration after the first dose of antibiotics (<a href="./references#CD004405-bbs2-0011" title="KingSM , LawB , LangleyJM , HeurterH , BremnerD , WangEE , et al. Dexamethasone therapy for bacterial meningitis: better never than late?. Canadian Journal of Infectious Diseases1994;5:210‐5. ">King 1994</a>; <a href="./references#CD004405-bbs2-0066" title="McIntyrePB , BerkeyCS , KingSM , SchaadUB , KilpiT , KanraGY , et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta‐analysis of randomized clinical trials since 1988. JAMA1997;278(11):925‐31. ">McIntyre 1997</a>). A RCT involving 301 adults with bacterial meningitis in European countries showed a beneficial effect of the corticosteroid dexamethasone on unfavourable outcome and mortality (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>). In this European study, dexamethasone or placebo was administered before or with the first dose of antibiotic (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>). The beneficial effect of dexamethasone on mortality was most apparent in patients with pneumococcal meningitis. In a post hoc analysis of this study, the beneficial effect of dexamethasone on mortality in patients with pneumococcal meningitis was attributable to a reduction in systemic complications (<a href="./references#CD004405-bbs2-0083" title="van deBeekD , deGansJ . Dexamethasone and pneumococcal meningitis. Annals of Internal Medicine2004;141(4):327. ">van de Beek 2004a</a>). Although speculative and not supported by clinical data, one implication of this finding might be that the effect of dexamethasone is not restricted to the first hours after administration (<a href="./references#CD004405-bbs2-0086" title="van deBeekD , deGansJ . Dexamethasone in adults with community‐acquired bacterial meningitis. Drugs2006;66(4):415‐27. ">van de Beek 2006b</a>). </p> <p>A meta‐analysis of individual patient data (<a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>) was performed with five recent large RCTs on adjunctive dexamethasone therapy in bacterial meningitis (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>). Data from 2029 patients from five trials were included and the aim of this analysis was to establish whether any subgroups of patients with acute bacterial meningitis might benefit from adjunctive dexamethasone. Extensive exploration of 15 pre‐specified subgroups did not show robust evidence that a particular subgroup would benefit; although there was a benefit in adults aged over 55 years (<a href="./references#CD004405-bbs2-0067" title="McIntyreP . Adjunctive dexamethasone in meningitis: does value depend on clinical setting?. Lancet Neurology2010;9:229‐31. ">McIntyre 2010</a>; <a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>). There were no differences in efficacy of adjunctive dexamethasone with regard to the timing of corticosteroids. </p> <p>In experimental pneumococcal meningitis, CSF bacterial concentrations appeared to be more important than the timing of dexamethasone therapy in influencing the antibacterial‐induced inflammatory response (<a href="./references#CD004405-bbs2-0065" title="LutsarI , FriedlandIR , JafriHS , WubbelL , AhmedA , TrujilloM , et al. Factors influencing the anti‐inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. Journal of Antimicrobial Chemotherapy2003;52(4):651‐5. ">Lutsar 2003</a>). Hence, there is a time period beyond which corticosteroid loses its effectiveness after the first (parenteral) administration of an antibiotic agent but this time interval has not been clearly defined. On the basis of the available evidence, dexamethasone should be preferably started before or with the first dose of antibiotic therapy. </p> <p>A long‐term follow‐up study on adjunctive dexamethasone treatment in tuberculous meningitis showed the initial beneficial effect of adjunctive dexamethasone was abolished because of delayed mortality within five years (<a href="./references#CD004405-bbs2-0080" title="TörökME ,  Nguyen DB , TranTH ,  Nguyen TB , ThwaitesGE , HoangTQ ,  etal . Dexamethasone and long‐term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One2011;6(12):e27821. ">Török 2011</a>). To assess the long‐term effects of adjunctive corticosteroid treatment in bacterial meningitis and determine whether a similar phenomenon could be identified, a long‐term follow‐up study was performed in participants included in the European Dexamethasone Study (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0054" title="FritzD , BrouwerMC , van deBeekD . Dexamethasone and long‐term survival in bacterial meningitis. Neurology2012;79(22):2177‐9. ">Fritz 2012</a>). The study included 228 of 246 evaluable participants surviving the initial trial period. After a median follow‐up of 13 years, mortality in the dexamethasone group was 22% compared to 33% in the placebo group (P = 0.029) (<a href="./references#CD004405-bbs2-0054" title="FritzD , BrouwerMC , van deBeekD . Dexamethasone and long‐term survival in bacterial meningitis. Neurology2012;79(22):2177‐9. ">Fritz 2012</a>). The authors conclude that the beneficial effect of dexamethasone that is obtained in the acute phase of the disease remains for years. This provides another reason to administer adjunctive corticosteroids in adult bacterial meningitis patients in high‐income countries. </p> <p>However, long‐term follow‐up studies of patients included in other RCTs are needed to confirm the persistence of benefit from adjunctive dexamethasone. </p> </section> <section id="CD004405-sec-0063"> <h4 class="title">Applicability of evidence</h4> <p>In children with acute bacterial meningitis, corticosteroids reduced hearing loss from 20.4% to 14.6% and severe hearing loss from 11.2% to 7.3%. A large proportion of included children had meningitis due to <i>H influenzae</i> type B, which has been virtually eliminated in high‐income countries since routine vaccination of children against this bacterium started (<a href="./references#CD004405-bbs2-0068" title="McIntyrePB , O'BrienKL , GreenwoodB , van deBeekD . Effect of vaccines on bacterial meningitis world‐wide. Lancet2012;380(9854):1703‐11. ">McIntyre 2012</a>; <a href="./references#CD004405-bbs2-0071" title="PeltolaH . Worldwide Haemophilus influenzae type B disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews2000;13(2):302‐17. ">Peltola 2000</a>; <a href="./references#CD004405-bbs2-0086" title="van deBeekD , deGansJ . Dexamethasone in adults with community‐acquired bacterial meningitis. Drugs2006;66(4):415‐27. ">van de Beek 2006b</a>). Nevertheless, subgroup analysis in children in high‐income countries showed a protective effect of adjunctive corticosteroids on severe hearing loss overall and a favourable point estimate for severe hearing loss due to non‐<i>Haemophilus</i> meningitis. The results of this review support the use of adjunctive corticosteroids in children in high‐income countries with meningitis due to all micro‐organisms based on the lack of evidence of adverse events (in general and micro‐organism specific) of dexamethasone in the corticosteroid‐treated group. However, as conclusive evidence is lacking for this subgroup, administration of corticosteroids to children with meningitis due to bacteria other than <i>H influenzae</i> remains controversial. </p> <p>Only one study in this analysis involved children with neonatal meningitis and showed a beneficial effect of corticosteroids on outcomes (<a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>). However, the study was relatively small and treatment groups were not well balanced with regards to patient age, culture positivity and causative micro‐organisms. Additional RCTs evaluating corticosteroids in neonatal meningitis need to be performed before definitive conclusions can be drawn on the role of dexamethasone treatment in neonatal meningitis. </p> <p>On the basis of the benefits of corticosteroid therapy in the adult population in high‐income countries, dexamethasone should be commenced in adults with suspected or proven community‐acquired bacterial meningitis in high‐income countries (<a href="./references#CD004405-bbs2-0085" title="van deBeekD , deGansJ , TunkelAR , WijdicksEFM . Community‐acquired bacterial meningitis in adults. New England Journal of Medicine2006;354(1):44‐53. [MEDLINE: 16394301] ">van de Beek 2006a</a>). For adults in low‐income countries, the use of corticosteroids is neither beneficial nor harmful. </p> <p>The use of steroids was associated with fewer cases of persistent fever and more cases of recurrent fever, but not with serious adverse events. However, definitions of adverse events used in the studies were heterogeneous and most studies had no specified criteria in advance, so under‐ascertainment is likely. </p> <p>Concerns have been raised over the interference by corticosteroids in CSF eradication of meningeal pathogens by reducing the blood‐brain barrier permeability and thereby the penetration of antibiotics in the subarachnoid space. Therapeutic failures have been described in adults treated with standard doses of vancomycin and adjunctive dexamethasone (<a href="./references#CD004405-bbs2-0089" title="ViladrichPF , GudiolF , LinaresJ , PallaresR , SabateI , RufiG , et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrobial Agents and Chemotherapy1991;35(12):2467‐72. ">Viladrich 1991</a>). However, two studies showed with repeated lumbar punctures that, in both adults and children, treatment with dexamethasone did not reduce vancomycin levels in the CSF (<a href="./references#CD004405-bbs2-0061" title="KlugmanKP , FriedlandIR , BradleyJS . Bactericidal activity against cephalosporin‐resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrobial Agents and Chemotherapy1995;39(9):1988‐92. ">Klugman 1995</a>; <a href="./references#CD004405-bbs2-0076" title="RicardJD , WolffM , LacheradeJC , MourvillierB , HidriN , BarnaudG , et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clinical Infectious Diseases2007;44:250‐5. ">Ricard 2007</a>). Although these results are reassuring, patients with pneumococcal meningitis who are treated with vancomycin and dexamethasone should still be carefully observed throughout therapy (<a href="./references#CD004405-bbs2-0085" title="van deBeekD , deGansJ , TunkelAR , WijdicksEFM . Community‐acquired bacterial meningitis in adults. New England Journal of Medicine2006;354(1):44‐53. [MEDLINE: 16394301] ">van de Beek 2006a</a>). </p> <p>In adults who survive acute bacterial meningitis, cognitive impairment occurs frequently (<a href="./references#CD004405-bbs2-0082" title="van deBeekD , SchmandB , DeGansJ , WeisfeltM , VaessenH , DankertJ , et al. Cognitive impairment in adults with good recovery after bacterial meningitis. Journal of Infectious Diseases2002;186(7):1047‐52. ">van de Beek 2002</a>; <a href="./references#CD004405-bbs2-0085" title="van deBeekD , deGansJ , TunkelAR , WijdicksEFM . Community‐acquired bacterial meningitis in adults. New England Journal of Medicine2006;354(1):44‐53. [MEDLINE: 16394301] ">van de Beek 2006a</a>). As corticosteroids may potentiate ischaemic injury to neurons (<a href="./references#CD004405-bbs2-0077" title="SapolskyRM , PulsinelliWA . Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science1985;229(4720):1397‐400. ">Sapolsky 1985</a>), it is important to know whether corticosteroids have beneficial effects on hearing loss and mortality but worsen cerebral cortical functioning (<a href="./references#CD004405-bbs2-0086" title="van deBeekD , deGansJ . Dexamethasone in adults with community‐acquired bacterial meningitis. Drugs2006;66(4):415‐27. ">van de Beek 2006b</a>). Neuropsychological outcome was evaluated in patients included in the European Dexamethasone Study who survived pneumococcal or meningococcal meningitis (<a href="./references#CD004405-bbs2-0090" title="WeisfeltM , HoogmanM , van deBeekD , deGansJ , DresschlerWA , SchmandB . Dexamethasone and long‐term outcome in adults with bacterial meningitis. Annals of Neurology2006;60(4):456‐68. ">Weisfelt 2006</a>). In 87 out of 99 eligible patients, 46 (53%) of whom were treated with dexamethasone and 41 (47%) of whom received placebo, no significant differences in outcome were found between patients in the dexamethasone and placebo groups (medium time between meningitis and testing was eight years). In another study on long‐term neuropsychological outcomes and dexamethasone in children, children who contracted pneumococcal meningitis and were treated with corticosteroids showed better academic achievements compared with children with pneumococcal meningitis who were not treated with adjunctive corticosteroids (<a href="./references#CD004405-bbs2-0035" title="OzenM , KanraG , KaraA , BakarEE , CeyhanM , SecmeerG , et al. Long‐term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis. Scandinavian Journal of Infectious Diseases2006;38(2):104‐9. ">Ozen 2006</a>). </p> </section> </section> <section id="CD004405-sec-0064"> <h3 class="title" id="CD004405-sec-0064">Quality of the evidence</h3> <p>Of the 25 randomised clinical trials included in the meta‐analysis four were of high quality, 14 of medium quality and seven of low quality. Although the number of high‐quality studies was low, the number of participants in these studies accounted for 45% of participants included in the meta‐analysis. Studies were mostly categorised as medium or low quality due to a lack of addressing missing data or because no intention‐to‐treat analysis was performed. For the analysis on severe hearing loss, significant heterogeneity between trials of high, medium and low quality was found. As studies of high quality showed no effect the results of this meta‐analysis should interpreted with caution. </p> <p>The sensitivity analysis showed that in a worst‐case scenario dexamethasone would have no beneficial or harmful effect on hearing loss or neurological sequelae. However, this analysis was heavily influenced by a single study accounting for 46% of missing values. When this study was left out a trend towards benefit of dexamethasone on any hearing loss was found (<a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>). Further sensitivity analyses showed that the effect of corticosteroids on overall short‐term neurological sequelae and mortality in pneumococcal meningitis would not be significant if the random‐effects model was used. </p> </section> <section id="CD004405-sec-0065"> <h3 class="title" id="CD004405-sec-0065">Potential biases in the review process</h3> <p>Several biases may have diminished the reliability of our results. The first confounding factor is selection bias. Several studies on childhood meningitis had exceptionally low mortality rates; nine studies had mortality rates of 3% or less. Mortality rates of childhood bacterial meningitis in previous reported studies ranged from 8% to 20% (<a href="./references#CD004405-bbs2-0044" title="BaraffLJ , LeeSI , SchrigerDL . Outcomes of bacterial meningitis in children: a meta‐analysis. Pediatric Infectious Disease Journal1993;12(5):389‐94. ">Baraff 1993</a>; <a href="./references#CD004405-bbs2-0047" title="BohrV , HansenB , JessenO , JohnsenN , KjersemH , KristensenHS , et al. Eight hundred and seventy‐five cases of bacterial meningitis. Part I of a three‐part series: clinical data, prognosis, and the role of specialised hospital departments. Journal of Infection1983;7(1):21‐30. ">Bohr 1983</a>). Inclusion of studies in the meta‐analysis with less severe illness, as reflected in the very low case‐fatality rates, will probably underestimate the protective effect of corticosteroids (<a href="./references#CD004405-bbs2-0056" title="GlasziouPP , IrwigLM . An evidence based approach to individualising treatment. BMJ1995;311(7016):1356‐9. ">Glasziou 1995</a>). Five studies had very high mortality rates (over 25%). For patients admitted in a late state of disease, adjuvant corticosteroids are less protective and might even be harmful (<a href="./references#CD004405-bbs2-0073" title="PrasadK , HainesT . Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?. Journal of Neurology, Neurosurgery and Psychiatry1995;59(1):31‐7. ">Prasad 1995</a>). Inclusion of such patients might again lead to an underestimation of the treatment effect. </p> <p>A second bias is introduced when participants are withdrawn (<a href="./references#CD004405-bbs2-0073" title="PrasadK , HainesT . Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?. Journal of Neurology, Neurosurgery and Psychiatry1995;59(1):31‐7. ">Prasad 1995</a>; <a href="./references#CD004405-bbs2-0020" title="QaziSA , KhanMA , MughalN , AhmadM , JoomroB , SakataY , et al. Dexamethasone and bacterial meningitis in Pakistan. Archives of Disease in Childhood1996;75(6):482‐8. ">Qazi 1996</a>). The analysis was based upon per‐protocol figures, as intention‐to‐treat (ITT) figures were only available for six studies (24%). A total of 211 participants were withdrawn after the randomisation process, often for unknown reasons. Reasons for withdrawal include ineligibility according to the trial criteria or inability to complete the treatment protocol (<a href="./references#CD004405-bbs2-0073" title="PrasadK , HainesT . Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?. Journal of Neurology, Neurosurgery and Psychiatry1995;59(1):31‐7. ">Prasad 1995</a>). Withdrawals on the grounds on ineligibility may have been influenced by knowledge of outcome; if so, this would advantage the corticosteroid regimen. Excluding participants because of an inability to complete the course of corticosteroids due to side effects (for example, upper gastrointestinal bleeding) clearly introduces bias in favour of the study medication, whereas withdrawals due to loss to follow‐up might favour the placebo group. In the Egyptian study, which was not placebo‐controlled and not double‐blinded, only three pathogens were cultured from the cerebral spinal fluid of enrolled participants, suggesting withdrawal of participants with other bacteria culture from CSF and those with negative CSF cultures (<a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>). </p> <p>A third bias is introduced by competing risks. The comparisons of hearing loss and neurologic sequelae (other than hearing loss) were made excluding all participants who died. Since mortality is possibly a treatment‐related outcome, the treatment groups that exclude fatality cases may not be comparable. Competing risks in this analysis will lead to an underestimation of the treatment effect of corticosteroids. </p> <p>Finally, the included studies were heterogeneous with respect to the study protocols. The first study was published in 1963 (<a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a>), the last in 2012 (<a href="./references#CD004405-bbs2-0015" title="Mathur NB , GargA , MishraTK . Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian Journal of Pediatrics2013;80(2):102‐7. ">Mathur 2013</a>). Several different study interventions were used. Therefore, study population effect sizes were calculated as risk ratios. </p> </section> <section id="CD004405-sec-0066"> <h3 class="title" id="CD004405-sec-0066">Agreements and disagreements with other studies or reviews</h3> <p>Four meta‐analyses on the use of adjunctive dexamethasone in adults were published, two in 2009 (<a href="./references#CD004405-bbs2-0042" title="AssiriAM , AlasmariFA , ZimmermanVA , BaddourLM , ErwinPJ , TleyjehIM . Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta‐analysis. Mayo Clinic Proceedings2009;84(5):403‐9. ">Assiri 2009</a>; <a href="./references#CD004405-bbs2-0088" title="VardakasKZ , MatthaiouDK , FalagasME . Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta‐analysis of randomized controlled trials. European Journal of Neurology2009;16:662‐73. ">Vardakas 2009</a>) and two in 2012 (<a href="./references#CD004405-bbs2-0048" title="BorchorstS , MollerK . The role of dexamethasone in the treatment of bacterial meningitis – a systematic review. Acta Anaesthesiologica Scandinavica2012;56:1210‐21. ">Borchorst 2012</a>; <a href="./references#CD004405-bbs2-0045" title="BernardoWM ,  AiresFT ,  SáFP . Effectiveness of the association of dexamethasone with antibiotic therapy in pediatric patients with bacterial meningitis. Revista da Associação Médica Brasileira2012;58(3):319‐22. ">Bernardo 2012</a>). The first meta‐analysis (<a href="./references#CD004405-bbs2-0088" title="VardakasKZ , MatthaiouDK , FalagasME . Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta‐analysis of randomized controlled trials. European Journal of Neurology2009;16:662‐73. ">Vardakas 2009</a>) concluded that dexamethasone was associated with a non‐significant decrease in mortality, but when the trial from Malawi was left out the decrease in mortality did reach significance. The reasons for excluding the Malawian trial were a HIV‐positive population, high mortality, poor general status and low human development index (HDI) (&lt; 0.5). However, other countries that were included had only slightly higher HDIs at the time of inclusion (<a href="./references#CD004405-bbs2-0008" title="GirgisNI , FaridZ , MikhailIA , FarragI , SultanY , KilpatrickME . Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal1989;8(12):848‐51. ">Girgis 1989</a>, Egypt 0.53; <a href="./references#CD004405-bbs2-0004" title="BhaumikS , BehariM . Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurology India1998;46:225‐8. ">Bhaumik 1998</a> India 0.53, <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a> Malawi 0.49). Several subgroup analyses showed that dexamethasone was most beneficial in patients with definite meningitis, in high‐ and medium‐income countries and patients with a short duration of symptoms. Out of four analyses eight subgroups consisted of only one or two studies, limiting the value of the meta‐analysis. Analyses on mortality and hearing loss in high‐ and medium‐income countries were similar to our results. The study by <a href="./references#CD004405-bbs2-0003" title="BennettIL , FinlandM , HamburgerM , KassEH , LepperM , WaisbrenBA . The effectiveness of hydrocortisone in the management of severe infections. JAMA1963;183(6):462‐5. ">Bennett 1963</a> was not included in this meta‐analysis for unknown reasons. The second meta‐analysis included four recent trials in adults (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0024" title="ThomasR , LeTulzoY , BougetJ , CamusC , MicheletC , LeCorreP , et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Medicine1999;25(5):475‐80. ">Thomas 1999</a>) and concluded that dexamethasone reduced mortality in high‐income countries (<a href="./references#CD004405-bbs2-0042" title="AssiriAM , AlasmariFA , ZimmermanVA , BaddourLM , ErwinPJ , TleyjehIM . Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta‐analysis. Mayo Clinic Proceedings2009;84(5):403‐9. ">Assiri 2009</a>). The third meta‐analysis (<a href="./references#CD004405-bbs2-0048" title="BorchorstS , MollerK . The role of dexamethasone in the treatment of bacterial meningitis – a systematic review. Acta Anaesthesiologica Scandinavica2012;56:1210‐21. ">Borchorst 2012</a>) included 29 randomised studies and had similar conclusions as the Cochrane 2010 meta‐analysis (<a href="./references#CD004405-bbs2-0092" title="Brouwer MC ,  McIntyreP ,  de GansJ ,  Prasad K ,  van de BeekD . Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD004405.pub3] ">Brouwer 2010a</a>), which were that adjunctive dexamethasone was beneficial in adults in high‐income countries, especially in patients with pneumococcal meningitis. The fourth meta‐analysis (<a href="./references#CD004405-bbs2-0045" title="BernardoWM ,  AiresFT ,  SáFP . Effectiveness of the association of dexamethasone with antibiotic therapy in pediatric patients with bacterial meningitis. Revista da Associação Médica Brasileira2012;58(3):319‐22. ">Bernardo 2012</a>) included only paediatric studies and concluded that adjunctive dexamethasone was not associated with a reduction in mortality, hearing loss or sequelae (<a href="./references#CD004405-bbs2-0045" title="BernardoWM ,  AiresFT ,  SáFP . Effectiveness of the association of dexamethasone with antibiotic therapy in pediatric patients with bacterial meningitis. Revista da Associação Médica Brasileira2012;58(3):319‐22. ">Bernardo 2012</a>). The reason why seven studies included in the Cochrane 2013 updated meta‐analysis were not included in the meta‐analysis of paediatric studies was not specified (<a href="./references#CD004405-bbs2-0093" title="BrouwerMC , McIntyreP , PrasadK , van deBeekD . Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD004405.pub4] ">Brouwer 2013</a>). According to the classification of study quality used, most of these studies were of similar quality to those that were included. </p> <p>The difference in efficacy of corticosteroids between high‐ and low‐income countries was mainly driven by two large studies from Malawi (<a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>), together representing 60% of included participants from low‐income countries. Participants included in these studies were often HIV‐positive, presented late in the disease course or received inappropriate antibiotic therapy (<a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>). There may be several reasons for the difference in efficacy of corticosteroids such as delayed presentation, clinical severity, underlying anaemia, malnutrition, the antibiotics used, HIV infection or other unidentified differences between populations. Recently, genetic factors were suggested to influence the patient's response to corticosteroids (<a href="./references#CD004405-bbs2-0051" title="BrouwerMC ,  van der EndeA ,  BaasF ,  van de BeekD . Genetic variation in GLCCI1 and dexamethasone in bacterial meningitis. Journal of Infection2012;65(5):465‐7. ">Brouwer 2012</a>). A study compared characteristics of children with culture‐positive community‐acquired bacterial meningitis in the Children's Unit, Queen Elizabeth Central Hospital, Blantyre, Malawi and in the Royal Liverpool Children's Hospital, UK from time periods before the introduction of vaccines (<a href="./references#CD004405-bbs2-0070" title="MolyneuxE , RiordanFA , WalshA . Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Annals of Tropical Paediatrics2006;26(1):29‐37. ">Molyneux 2006</a>). Children in Malawi presented later and were more often comatose and malnourished, compared to children in Britain. Mortality from bacterial meningitis in children in Malawi was much higher than in children in Britain (41% versus 7%), even when infected with the same organism. Several studies have shown that a delay in initiation of antibiotic treatment is associated with worse outcome in bacterial meningitis (<a href="./references#CD004405-bbs2-0069" title="McMillanDA , LinCY , AroninSI , QuagliarelloVJ . Community‐acquired bacterial meningitis in adults: categorization of causes and timing of death. Clinical Infectious Diseases2001;33:969‐75. ">McMillan 2001</a>; <a href="./references#CD004405-bbs2-0063" title="Køster‐RasmussenR , KorshinA , MeyerCN . Antibiotic treatment delay and outcome in acute bacterial meningitis. Journal of Infection2008;57:449‐54. ">Køster‐Rasmussen 2008</a>; <a href="./references#CD004405-bbs2-0074" title="ProulxN , FréchetteD , ToyeB , ChanJ , KravcikS . Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM2005;94:291‐8. ">Proulx 2005</a>). A meta‐analysis on timing of steroids with respect to initial symptoms could not be performed because outcome data were not specified for patients presenting early or late during clinical course in any of the studies. Nevertheless, we stress the need for early diagnosis and treatment. </p> <p>A meta‐analysis of individual patient data was performed with five large RCTs (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>; <a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>). Data from 2029 patients from five trials were included in the analysis (833 (41.0%) aged &lt; 15 years). HIV infection was confirmed or likely in 580 (28.6%) patients and bacterial meningitis was confirmed in 1639 (80.8%). Dexamethasone was not associated with a significant reduction in death (270 of 1019 (26.5%) on dexamethasone versus 275 of 1010 (27.2%) on placebo; odds ratio (OR) 0.97, 95% CI 0.79 to 1.19), death or severe neurological sequelae or bilateral severe deafness (42.3% versus 44.3%; OR 0.92, 95% CI 0.76 to 1.11), death or any neurological sequelae or any hearing loss (54.2% versus 57.4%; OR 0.89, 95% CI 0.74 to 1.07), or death or severe bilateral hearing loss (36.4% versus 38.9%; OR 0.89, 95% CI 0.73 to 1.69). However, dexamethasone reduced hearing loss among survivors (24.1% versus 29.5%; OR 0.77, 95% CI 0.60 to 0.99, P = 0.04). Dexamethasone had no effect in any of the pre‐specified subgroups, including specific causative organisms, pre‐dexamethasone antibiotic treatment, HIV status or age. The differences between Malawi and the other clinical settings call into question the appropriateness of summary measures that combine the results, even if statistical tests of heterogeneity are deemed acceptable. Mortality rates in the two studies from Malawi were three to five‐fold higher than in the studies from Europe, South America and Vietnam (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>; <a href="./references#CD004405-bbs2-0016" title="MolyneuxEM , WalshAL , ForsythH , TemboM , MwenechanyaJ , KayiraK , et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet2002;360(9328):211‐8. ">Molyneux 2002</a>; <a href="./references#CD004405-bbs2-0017" title="NguyenTH , TranTH , ThwaitesG , LyVC , DinhXS , Ho DangTN , et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine2007;357:2431‐40. ">Nguyen 2007</a>; <a href="./references#CD004405-bbs2-0019" title="PeltolaH , RoineI , FernándezJ , ZavalaI , AyalaSG , MataAG , et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double‐blind, placebo‐controlled trial. Clinical Infectious Diseases2007;45:1277‐86. ">Peltola 2007</a>; <a href="./references#CD004405-bbs2-0022" title="ScarboroughM , GordonSB , WhittyCJ , FrenchN , NjalaleY , ChitaniA , et al. Corticosteroids for bacterial meningitis in adults in sub‐Saharan Africa. New England Journal of Medicine2007;357:2441‐50. ">Scarborough 2007</a>). In subgroups of the individual patient data meta‐analysis, there were several instances in which the I<sup>2</sup> statistic was more than 50%, which indicates at least moderate heterogeneity (<a href="./references#CD004405-bbs2-0067" title="McIntyreP . Adjunctive dexamethasone in meningitis: does value depend on clinical setting?. Lancet Neurology2010;9:229‐31. ">McIntyre 2010</a>). This current Cochrane review confirms the beneficial effect of corticosteroids on hearing loss that was found in the subgroups of the individual meta‐analysis (<a href="./references#CD004405-bbs2-0087" title="van deBeekD , FarrarJJ , deGansJ , MaiNT , MolyneuxEM , PeltolaH , et al. Adjunctive dexamethasone in bacterial meningitis: a meta‐analysis of individual patient data. Lancet Neurology2010;9:254‐63. ">van de Beek 2010</a>). Treatment with adjunctive corticosteroids was not associated with harm. In order to establish with certainty whether or not dexamethasone has a place in the treatment of bacterial meningitis, a large multinational RCT in that subgroup would be necessary. Such a trial would need to include approximately 13,500 participants to show an odds ratio (OR) of 0.9 with a power of 90% in a population with 27% risk of death in the placebo group, and is therefore unlikely to be performed or finished in the next decade. Meanwhile, results of our analysis support the use of corticosteroids in children and adults with community‐acquired bacterial meningitis in high‐income countries. </p> <section id="CD004405-sec-0067"> <h4 class="title">Implementation studies</h4> <p>Seven studies evaluated the implementation of adjunctive dexamethasone treatment and its effect on the outcome of bacterial meningitis (<a href="./references#CD004405-bbs2-0046" title="BodilsenJ , Dalager‐PedersenM , SchønheyderHC , NielsenH . Dexamethasone treatment and prognostic factors in community‐acquired bacterial meningitis: a Danish retrospective population‐based cohort study. Scandinavian Journal of Infectious Diseases2014;46:418‐25. ">Bodilsen 2014</a>; <a href="./references#CD004405-bbs2-0049" title="BrouwerMC ,  HeckenbergSG , deGansJ , SpanjaardL , ReitsmaJB , van deBeekD . Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology2010;75(17):1533‐9. ">Brouwer 2010b</a>; <a href="./references#CD004405-bbs2-0052" title="CastelblancoRL , LeeM , HasbunR . Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population‐based observational study. Lancet Infectious Diseases2014;14:813‐9. ">Castelblanco 2014</a>; <a href="./references#CD004405-bbs2-0053" title="Cornelis AS , Hachimi‐IdrissiS . The use of dexamethasone in bacterial meningitis in children and adults: a retrospective analysis. ISRN Pediatrics2011;2011:380283. ">Cornelis 2011</a>; <a href="./references#CD004405-bbs2-0059" title="HeckenbergSG , BrouwerMC , van derEndeA , van deBeekD . Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology2012;79(15):1563‐9. ">Heckenberg 2012b</a>; <a href="./references#CD004405-bbs2-0062" title="KoopmansMM , BrouwerMC , BijlsmaMW , BovenkerkS , KeijzersW , van derEndeA , et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clinical Infectious Diseases2013;57:247‐53. ">Koopmans 2013</a>; <a href="./references#CD004405-bbs2-0072" title="PeterkovićV ,  TrkuljaV ,  KutlešaM ,  KrajinovićV ,  LepurD . Dexamethasone for adult community‐acquired bacterial meningitis: 20 years of experience in daily practice. Journal of Neurology2012;259(2):225‐36. ">Peterković 2012</a>). Three studies compared the prognosis of adult pneumococcal, meningococcal and <i>Listeria monocytogenes</i> meningitis between two nationwide prospective cohort studies; one was performed before and the other after the implementation of adjunctive dexamethasone (<a href="./references#CD004405-bbs2-0049" title="BrouwerMC ,  HeckenbergSG , deGansJ , SpanjaardL , ReitsmaJB , van deBeekD . Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology2010;75(17):1533‐9. ">Brouwer 2010b</a>; <a href="./references#CD004405-bbs2-0059" title="HeckenbergSG , BrouwerMC , van derEndeA , van deBeekD . Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology2012;79(15):1563‐9. ">Heckenberg 2012b</a>; <a href="./references#CD004405-bbs2-0062" title="KoopmansMM , BrouwerMC , BijlsmaMW , BovenkerkS , KeijzersW , van derEndeA , et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clinical Infectious Diseases2013;57:247‐53. ">Koopmans 2013</a>). The studies showed that after the introduction of adjunctive dexamethasone, 84% of patients with pneumococcal meningitis, 89% of adults with meningococcal meningitis and 53% of <i>L monocytogenes</i> meningitis received the recommended four‐day regimen (40 mg/day in four doses). The mortality from pneumococcal meningitis decreased from 30% to 20% after the introduction of dexamethasone (P value = 0.001) and the rate of hearing loss decreased from 22% to 12% (P value = 0.001) (<a href="./references#CD004405-bbs2-0049" title="BrouwerMC ,  HeckenbergSG , deGansJ , SpanjaardL , ReitsmaJB , van deBeekD . Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology2010;75(17):1533‐9. ">Brouwer 2010b</a>). Meningococcal disease mortality declined from 7% to 4% and hearing loss from 8% to 3%, but these differences did not reach statistical significance (<a href="./references#CD004405-bbs2-0059" title="HeckenbergSG , BrouwerMC , van derEndeA , van deBeekD . Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology2012;79(15):1563‐9. ">Heckenberg 2012b</a>). No evidence of harm from dexamethasone was identified in studies on pneumococcal and meningococcal meningitis. The beneficial effect of dexamethasone on pneumococcal meningitis was similar to that identified in the European Dexamethasone Study (<a href="./references#CD004405-bbs2-0006" title="deGansJ , van deBeekD . Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine2002;347(20):1549‐56. ">de Gans 2002</a>). For listerial meningitis, an increase in unfavourable outcome from 27% to 61% was observed between the first and second cohort study (<a href="./references#CD004405-bbs2-0062" title="KoopmansMM , BrouwerMC , BijlsmaMW , BovenkerkS , KeijzersW , van derEndeA , et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clinical Infectious Diseases2013;57:247‐53. ">Koopmans 2013</a>). In a multivariate analysis bacterial genotype was found to be the main cause of the poorer prognosis. Dexamethasone was not associated with a change in mortality, hearing loss or sequelae in listerial meningitis. However, as adjunctive dexamethasone treatment was another major change between cohorts, it was suggested to discontinue dexamethasone when <i>L monocytogenes</i> is identified. A nationwide retrospective study from Denmark showed dexamethasone was administered to 60% of meningitis cases between 2008 and 2012 compared to 37% between 2003 and 2007 (<a href="./references#CD004405-bbs2-0046" title="BodilsenJ , Dalager‐PedersenM , SchønheyderHC , NielsenH . Dexamethasone treatment and prognostic factors in community‐acquired bacterial meningitis: a Danish retrospective population‐based cohort study. Scandinavian Journal of Infectious Diseases2014;46:418‐25. ">Bodilsen 2014</a>). Dexamethasone treatment was associated with a significant decrease in the risk of an unfavourable outcome (33% versus 53%) and mortality (15% versus 24%). The implementation studies provide additional (class III) evidence that adjunctive dexamethasone is beneficial in adults with bacterial meningitis in high‐income countries. </p> <p>In a population‐based observational study from the USA, incidence and mortality of bacterial meningitis due to the five most common pathogens between 1997 and 2010 were studied in a network database (<a href="./references#CD004405-bbs2-0052" title="CastelblancoRL , LeeM , HasbunR . Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population‐based observational study. Lancet Infectious Diseases2014;14:813‐9. ">Castelblanco 2014</a>). The study showed that over time mortality declined. This was attributed to the publication of the IDSA guideline of 2004, which advised adjunctive dexamethasone for all suspected bacterial meningitis cases (<a href="./references#CD004405-bbs2-0052" title="CastelblancoRL , LeeM , HasbunR . Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population‐based observational study. Lancet Infectious Diseases2014;14:813‐9. ">Castelblanco 2014</a>). However, data on dexamethasone use were not available and therefore a causal relation could not be established. </p> <p>Retrospective studies in Belgium and Croatia evaluated whether the use of dexamethasone improved prognosis in adults (<a href="./references#CD004405-bbs2-0072" title="PeterkovićV ,  TrkuljaV ,  KutlešaM ,  KrajinovićV ,  LepurD . Dexamethasone for adult community‐acquired bacterial meningitis: 20 years of experience in daily practice. Journal of Neurology2012;259(2):225‐36. ">Peterković 2012</a>), or both adults and children (<a href="./references#CD004405-bbs2-0053" title="Cornelis AS , Hachimi‐IdrissiS . The use of dexamethasone in bacterial meningitis in children and adults: a retrospective analysis. ISRN Pediatrics2011;2011:380283. ">Cornelis 2011</a>). Both studies showed no effect of dexamethasone. However, in both studies the rationale to give or withhold dexamethasone was unclear and therefore confounding by indication (patients with severe sickness get more medication, i.e. dexamethasone, but still have a worse prognosis) is a major problem in these studies, as is the retrospective design. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004405-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD004405-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD004405-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All patients, outcome: 1.1 Mortality." data-id="CD004405-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All patients, outcome: 1.2 Severe hearing loss." data-id="CD004405-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.2 Severe hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All patients, outcome: 1.3 Any hearing loss." data-id="CD004405-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All patients, outcome: 1.6 Adverse events." data-id="CD004405-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All patients, outcome: 1.6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 1 Mortality." data-id="CD004405-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 2 Severe hearing loss." data-id="CD004405-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 2 Severe hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 3 Any hearing loss." data-id="CD004405-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 4 Short‐term neurological sequelae." data-id="CD004405-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 4 Short‐term neurological sequelae.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 5 Long‐term neurological sequelae." data-id="CD004405-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 5 Long‐term neurological sequelae.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All patients, Outcome 6 Adverse events." data-id="CD004405-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 All patients, Outcome 6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Children, Outcome 1 Mortality." data-id="CD004405-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Children, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Children, Outcome 2 Severe hearing loss." data-id="CD004405-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Children, Outcome 2 Severe hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Children, Outcome 3 Any hearing loss." data-id="CD004405-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Children, Outcome 3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adults, Outcome 1 Mortality." data-id="CD004405-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Adults, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adults, Outcome 2 Any hearing loss." data-id="CD004405-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Adults, Outcome 2 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Adults, Outcome 3 Short‐term neurological sequelae." data-id="CD004405-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Adults, Outcome 3 Short‐term neurological sequelae.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Causative species, Outcome 1 Mortality." data-id="CD004405-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Causative species, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Causative species, Outcome 2 Severe hearing loss in children ‐ non‐Haemophilus influenzae species." data-id="CD004405-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Causative species, Outcome 2 Severe hearing loss in children ‐ non‐<i>Haemophilus influenzae</i> species. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Causative species, Outcome 3 Severe hearing loss in children ‐ Haemophilus influenzae." data-id="CD004405-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Causative species, Outcome 3 Severe hearing loss in children ‐ <i>Haemophilus influenzae</i>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 1 Mortality ‐ all patients." data-id="CD004405-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 1 Mortality ‐ all patients.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 2 Severe hearing loss ‐ all patients." data-id="CD004405-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 2 Severe hearing loss ‐ all patients.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 3 Any hearing loss." data-id="CD004405-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 4 Short‐term neurological sequelae ‐ all patients." data-id="CD004405-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 4 Short‐term neurological sequelae ‐ all patients. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 5 Mortality ‐ children." data-id="CD004405-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 5 Mortality ‐ children.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 6 Severe hearing loss ‐ children." data-id="CD004405-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 6 Severe hearing loss ‐ children.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 7 Short‐term neurological sequelae ‐ children." data-id="CD004405-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 7 Short‐term neurological sequelae ‐ children.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 8 Severe hearing loss in children due to non‐Haemophilus influenzae species." data-id="CD004405-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 8 Severe hearing loss in children due to non‐<i>Haemophilus influenzae</i> species. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 9 Mortality ‐ adults." data-id="CD004405-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 9 Mortality ‐ adults.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Income of countries, Outcome 10 Any hearing loss adults." data-id="CD004405-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Income of countries, Outcome 10 Any hearing loss adults.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of steroids, Outcome 1 Mortality." data-id="CD004405-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Timing of steroids, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of steroids, Outcome 2 Severe hearing loss." data-id="CD004405-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Timing of steroids, Outcome 2 Severe hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of steroids, Outcome 3 Any hearing loss." data-id="CD004405-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Timing of steroids, Outcome 3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of steroids, Outcome 4 Short‐term neurologic sequelae." data-id="CD004405-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Timing of steroids, Outcome 4 Short‐term neurologic sequelae.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Study quality, Outcome 1 Mortality." data-id="CD004405-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Study quality, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Study quality, Outcome 2 Severe hearing loss." data-id="CD004405-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Study quality, Outcome 2 Severe hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Study quality, Outcome 3 Any hearing loss." data-id="CD004405-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Study quality, Outcome 3 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Study quality, Outcome 4 Short‐term neurological sequelae." data-id="CD004405-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Study quality, Outcome 4 Short‐term neurological sequelae.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 1 Severe hearing loss." data-id="CD004405-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 1 Severe hearing loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 2 Any hearing loss." data-id="CD004405-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 2 Any hearing loss.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 3 Short‐term neurological sequelae." data-id="CD004405-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 3 Short‐term neurological sequelae. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004405-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/urn:x-wiley:14651858:media:CD004405:CD004405-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_t/tCD004405-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 4 Long‐term neurological sequelae." data-id="CD004405-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis ‐ worst‐case scenario, Outcome 4 Long‐term neurological sequelae. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/media/CDSR/CD004405/image_n/nCD004405-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004405-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Comparison of corticosteroids against placebo in patients with acute bacterial meningitis</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute bacterial meningitis<br/> <b>Setting:</b> hospitals, low‐ and high‐income countries<br/> <b>Intervention:</b> corticosteroids<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.90<br/> (0.80 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4121<br/> (25 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊖⊖</p> <p>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000<br/> (159 to 201) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>188 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/> (150 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Severe hearing loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.67<br/> (0.51 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2437<br/> (17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62 per 1000<br/> (47 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000<br/> (20 to 35) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Any hearing loss</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.74<br/> (0.63 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2785<br/> (20 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000<br/> (120 to 166) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>233 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>173 per 1000<br/> (147 to 203) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Short‐term neurological sequelae</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.83<br/> (0.69 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1756<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊖</p> <p>HIGH</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179 per 1000<br/> (149 to 216) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>184 per 1000<br/> (153 to 222) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Adverse events ‐ recurrent fever</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.27<br/> (1.09 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1723<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊖⊖<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000<br/> (241 to 326) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>357 per 1000<br/> (307 to 413) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Variable mortality between studies, consistent with differences across the world in meningitis prognosis. </p> <p><sup>2</sup>Different definitions used for recurrent fever makes this imprecise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/full#CD004405-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All patients</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.51, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2785</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.63, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Short‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.69, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Long‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Gastrointestinal bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.86, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Herpes zoster infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.86, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Persistent fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Recurrent fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1723</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.09, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Fungal infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [0.56, 5.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Arthritis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.27, 1.53]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Children</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.74, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.49, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1961</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.61, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adults</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.53, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>844</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.56, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Short‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.51, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Causative species</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Haemophilus influenzae </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.53, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Streptococcus pneumoniae </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.72, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Neisseria meningitidis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.35, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss in children ‐ non‐<i>Haemophilus influenzae</i> species <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>860</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.65, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Severe hearing loss in children ‐ <i>Haemophilus influenzae</i> <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.20, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Causative species</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Income of countries</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality ‐ all patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.75, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.67, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.63, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss ‐ all patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.58, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>944</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.72, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.35, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.69, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1051</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.76, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.45, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Short‐term neurological sequelae ‐ all patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1814</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.70, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>735</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.81, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.48, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.77, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.61, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Severe hearing loss ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1531</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.56, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.69, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.35, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Short‐term neurological sequelae ‐ children <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.81, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.46, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe hearing loss in children due to non‐<i>Haemophilus influenzae</i> species <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.66, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.72, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.41, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mortality ‐ adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.82, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.86, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>881</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.56, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Any hearing loss adults <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>844</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.47, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Low‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.49, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 High‐income countries</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.36, 0.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Income of countries</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Timing of steroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3940</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.73, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Before or with first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.69, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 After first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.55, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.64, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Before or with first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.62, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 After first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.47, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.68, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Before or with antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.70, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 After first dose of antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.43, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Short‐term neurologic sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.71, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Before or with first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 After first dose antibiotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.47, 1.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Timing of steroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Study quality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.85, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1793</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.88, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.57, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Low quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>851</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.60, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.55, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>857</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.69, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1051</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.29, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Low quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>534</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.20, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.69, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.73, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Medium quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.62, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Low quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.38, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Short‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.70, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.77, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.45, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Low quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.35, 1.95]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Study quality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004405-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analysis ‐ worst‐case scenario</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Severe hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.81, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any hearing loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.71, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Short‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.82, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Long‐term neurological sequelae <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.78, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analysis ‐ worst‐case scenario</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004405.pub5/references#CD004405-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004405.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004405-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004405-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004405-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD004405-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004405-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004405-note-0002">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004405\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004405\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004405\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004405\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004405\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=JmNqPX1V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004405.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004405.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004405.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004405.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004405.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716049544"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004405.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716049547"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004405.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d960748c8f409',t:'MTc0MDcxNjA0OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 